Medical Billing FAQ — 250+ Expert Answers to Your Billing Questions

Medical billing is the process of submitting claims to insurance companies for healthcare services and managing the payment cycle.

Medical billing is the process of submitting and following up on claims with health insurance companies to receive payment for services rendered by healthcare providers. The process begins when a patient receives care, continues through coding and claim submission, and ends when payment is received and posted. Key steps include patient registration, insurance verification, charge capture, coding (CPT and ICD-10), claim submission, payment posting, and denial management.

Appeal denied claims by reviewing denial reasons, gathering documentation, and submitting a formal appeal within payer timeframes.

The claim appeal process typically follows these steps: (1) Review the denial reason code and EOB/ERA; (2) Determine if the denial is correctable by resubmission or requires a formal appeal; (3) Gather supporting documentation (medical records, authorization letters, coding rationale); (4) Submit a written appeal within the payer's timeframe (typically 60-180 days); (5) Include a cover letter referencing the claim, denial reason, and supporting evidence; (6) Track the appeal and follow up. Medicare has 5 levels of appeal. Commercial payers typically have 2-3 levels. Success rates for well-documented appeals range from 50-70%.

Claim scrubbing is automated review of claims for errors before submission, checking codes, modifiers, and payer rules.

Claim scrubbing is the automated review of healthcare claims before submission to identify and correct errors that would cause denials or rejections. Scrubbing software checks for: (1) Valid CPT/ICD-10 code combinations, (2) Proper modifier usage, (3) National Correct Coding Initiative (NCCI) edits, (4) Missing required fields, (5) Duplicate claims, (6) Age/gender-specific code appropriateness, (7) Local coverage determinations (LCDs), and (8) Payer-specific rules. Effective claim scrubbing can achieve clean claim rates above 95%, significantly reducing denials and accelerating payment.

A charge master lists all billable services with their codes and prices; update annually with fees at 200-300% of Medicare.

A charge master (also called a charge description master or CDM) is a comprehensive listing of all billable items and services offered by a healthcare provider, including their associated CPT/HCPCS codes and standard charges. Best practices for maintenance include: (1) Annual review and update of all CPT and HCPCS codes for additions, deletions, and revisions; (2) Setting charges at 200-300% of Medicare rates to avoid leaving money on the table with commercial payers; (3) Ensuring code-charge consistency; (4) Removing deleted codes; (5) Adding new services promptly; (6) Benchmarking against regional and national data.

Top coding certifications include CPC, CCS, COC, and CIC from AAPC and AHIMA organizations.

Major medical coding certifications include: AAPC certifications — CPC (Certified Professional Coder), CPC-A (Apprentice), COC (Certified Outpatient Coder), CIC (Certified Inpatient Coder), and specialty-specific credentials (CIRCC, CPMA, CEMC, etc.). AHIMA certifications — CCS (Certified Coding Specialist), CCS-P (Certified Coding Specialist-Physician-based), CCA (Certified Coding Associate), and RHIT/RHIA for health information management. Most employers require at least one recognized certification, with CPC and CCS being the most widely sought.

Coding translates medical services into standardized codes; billing uses those codes to submit claims and manage payments.

Medical coding involves translating healthcare diagnoses, procedures, and services into standardized alphanumeric codes (CPT, ICD-10, HCPCS). Medical billing uses those codes to create and submit claims to insurance companies and manage the reimbursement process. Coders focus on accuracy of code assignment based on clinical documentation, while billers focus on claim submission, follow-up, payment posting, and denial management. Both roles are essential to the revenue cycle.

Rejections happen before processing due to data errors; denials happen after adjudication when claims are deemed unpayable.

A claim rejection occurs before processing — the claim is returned because it contains invalid or missing information and cannot enter the adjudication process. Common reasons include invalid member ID, missing NPI, or formatting errors. Rejected claims can be corrected and resubmitted without an appeal. A claim denial occurs after the payer has processed and adjudicated the claim but determined it is not payable. Denials require investigation, may need an appeal, and are subject to timely filing limits for resubmission. Tracking both separately helps identify different process improvements.

The No Surprises Act prevents surprise out-of-network bills for emergency services and requires good faith estimates for self-pay patients.

The No Surprises Act (effective January 2022) protects patients from unexpected out-of-network charges in certain scenarios: (1) Emergency services at out-of-network facilities must be billed at in-network rates; (2) Out-of-network providers at in-network facilities cannot balance bill patients without prior notice and consent; (3) Good faith estimates must be provided to uninsured/self-pay patients; (4) An independent dispute resolution (IDR) process resolves payment disputes between providers and payers. Practices must provide notice and consent forms when applicable and implement good faith estimate processes.

Credentialing verifies provider qualifications for insurance networks; takes 90-180 days and is required for claim payment.

Credentialing is the process of verifying a healthcare provider's qualifications to participate in insurance networks. Without active credentials, claims submitted under that provider will be denied. The credentialing process includes: (1) Completing CAQH ProView profile, (2) Submitting applications to individual payers, (3) Providing verification of education, licensure, DEA registration, malpractice insurance, and board certification, (4) Passing background checks. The process typically takes 90-180 days, and re-credentialing occurs every 2-3 years. Backdating of effective dates is not always possible, so starting early is critical.

CMS-1500 is used for professional claims; UB-04 for institutional claims. Electronic equivalents are 837P and 837I formats.

The CMS-1500 (previously HCFA-1500) is the standard claim form used by non-institutional providers for billing professional services to Medicare, Medicaid, and most commercial payers. The form contains 33 fields covering patient information, provider information, diagnosis codes, procedure codes, and charges. The UB-04 (CMS-1450) form is used by institutional providers (hospitals, skilled nursing facilities). Electronic claims use the ANSI X12 837P format (professional) or 837I format (institutional), which contain the same data elements as the paper forms.

Orthopedic surgeries include 90-day or 10-day global periods; use modifiers 24, 78, or 79 for separate services.

Most orthopedic surgical procedures include a global surgical period (typically 90 days for major surgeries, 10 days for minor surgeries). During this period, routine post-operative care is included in the surgical fee and should not be billed separately. However, services for unrelated conditions, complications requiring a return to the operating room, and diagnostic services unrelated to the surgery can be billed with appropriate modifiers (-24 for unrelated E/M, -78 for return to OR for related complication, -79 for unrelated procedure).

Code biopsies by type (tangential, punch, incisional) and excisions by anatomical site and lesion size.

Dermatology biopsies are coded using 11102 (tangential biopsy, first lesion) and +11103 (each additional lesion), 11104 (punch biopsy, first lesion) and +11105 (each additional), or 11106 (incisional biopsy, first lesion) and +11107 (each additional). Excisions are coded from the 11400-11646 range based on site (trunk, extremities, face) and size (including margins). When a biopsy leads to an excision on the same day, the biopsy is typically bundled unless done on a separate lesion. Pathology interpretation (88305) can be billed separately if the dermatologist performs their own interpretation.

CDT codes (D-prefix) are for dental procedures; CPT codes cover medical procedures. Some dental services can be billed to medical insurance.

CDT (Current Dental Terminology) codes are maintained by the American Dental Association and are used exclusively for dental procedures. They follow a D-prefix format (e.g., D0120 for periodic oral evaluation). CPT codes are maintained by the AMA and cover medical procedures. Some dental procedures may be billable to medical insurance using CPT codes, particularly oral surgery, TMJ treatment, and trauma-related dental services. Medical-dental cross-coding can maximize reimbursement when procedures have both dental and medical applications.

Bill well-child visits with 99381-99395 codes plus separate vaccine administration and product codes.

Well-child visits use preventive medicine CPT codes: 99381-99385 (new patient by age) and 99391-99395 (established patient by age). Immunizations require two components: the vaccine product code (90460-90461 for counseling-based, or 90471-90474 for administration) and the specific vaccine code (e.g., 90707 for MMR, 90686 for influenza). If a significant, separately identifiable problem is addressed during a well visit, an E/M code with modifier -25 can be added. The Vaccines for Children (VFC) program affects billing for government-insured patients.

Bill CCM with 99490 (20 min/month) for patients with 2+ chronic conditions; requires consent and care plan.

Chronic Care Management (CCM) is billed using CPT 99490 (20 minutes of clinical staff time per calendar month), 99491 (30 minutes of physician/qualified healthcare professional time), and 99439 (each additional 20 minutes). Requirements include: (1) Patient must have two or more chronic conditions expected to last at least 12 months; (2) Written consent from the patient; (3) A comprehensive care plan; (4) 24/7 access for urgent needs; (5) Continuity of care with a designated practitioner. Only one practitioner can bill CCM per patient per month.

Common cardiology CPT codes include 93000 (ECG), 93306 (echo), 93350 (stress echo), and 93458 (cath).

The most commonly billed cardiology CPT codes include: 93000 (Electrocardiogram with interpretation), 93306 (Transthoracic echocardiography), 93350 (Stress echocardiography), 93458 (Left heart catheterization), 93010 (ECG interpretation only), 93880 (Duplex scan of extracranial arteries), 93798 (Cardiac rehabilitation), and E/M codes 99213-99215 for office visits. Cardiology practices should also be familiar with modifier usage for technical (-TC) and professional (-26) components of diagnostic studies.

Common mental health codes include 90834 (45-min therapy), 90837 (60-min), 90791 (diagnostic eval), and 90853 (group).

Key mental health CPT codes include: 90834 (individual psychotherapy, 45 minutes), 90837 (individual psychotherapy, 60 minutes), 90832 (individual psychotherapy, 30 minutes), 90847 (family psychotherapy with patient present), 90846 (family psychotherapy without patient present), 90853 (group psychotherapy), 90791 (psychiatric diagnostic evaluation), 90792 (psychiatric diagnostic evaluation with medical services), and add-on code 90833/90836/90838 for psychotherapy performed with E/M services. Telehealth sessions use the same codes with modifier -95 or place of service 10.

Bill telehealth with standard E/M codes using POS 10 or 02 and modifier -95; verify payer-specific telehealth policies.

Telehealth billing in family medicine uses the same E/M codes (99202-99215) with place of service 10 (telehealth in patient's home) or POS 02 (telehealth facility). Add modifier -95 for synchronous telemedicine when required by payer. Key considerations: (1) Audio-visual technology must be used for most payers (some allow audio-only with modifier -93); (2) Verify payer-specific telehealth policies as coverage varies; (3) Document patient consent for telehealth; (4) Note patient location and ensure the patient is in an eligible state; (5) Check state licensure requirements; (6) Some payers reimburse at the same rate as in-person visits, while others may reduce rates.

Determine primary/secondary dental plans, bill primary first, then submit to secondary with primary EOB for maximum coverage.

Dual dental coverage coordination follows specific rules: (1) Determine primary and secondary coverage using the birthday rule for dependents or subscriber-first rule; (2) Submit to the primary carrier first; (3) After receiving primary EOB, submit to secondary with the primary EOB attached; (4) The secondary payer typically covers remaining patient responsibility up to their allowed amount; (5) Total reimbursement cannot exceed 100% of the total fee; (6) Non-duplication of benefits clauses may limit secondary payment; (7) Some plans use a carve-out method vs. traditional COB; (8) Verify both plans' annual maximums are tracked separately.

Bill psychological testing with 96130-96131 (evaluation) and 96136-96139 (administration); prior auth often required.

Psychological testing is billed using CPT 96130-96131 for test evaluation by the psychologist (96130 for the first hour, +96131 for each additional hour) and 96136-96139 for test administration. Neuropsychological testing uses 96132-96133 for evaluation (96132 first hour, +96133 additional) and the same administration codes. Key considerations: (1) Both face-to-face and non-face-to-face time count; (2) Technicians can administer under supervision using 96138-96139; (3) Prior authorization is often required; (4) Many payers limit annual testing hours; (5) Include diagnostic code supporting medical necessity (commonly F09, R41.3, or specific developmental/cognitive codes).

Select E/M level based on 2 of 3 MDM elements (problems, data, risk) or total time spent on the encounter.

Under current guidelines, E/M level is determined by either Medical Decision Making (MDM) or total time. For MDM-based selection: (1) Evaluate the number and complexity of problems addressed (minimal, low, moderate, high); (2) Assess data reviewed — ordering/reviewing tests, independent interpretation, discussion with external physician; (3) Determine risk — including risk of morbidity, drug therapy management, and decisions about hospitalization. Two of three MDM elements must meet or exceed the level. For time-based selection, count all physician time on the date of encounter including documentation, care coordination, and counseling. E/M 99213 requires low MDM, 99214 moderate, 99215 high.

E/M coding uses Medical Decision Making (2 of 3 elements) or total time for code level selection.

The current E/M coding guidelines (effective since 2023 for all E/M categories) base code selection on Medical Decision Making (MDM) or total time. MDM has three components: (1) Number and complexity of problems addressed, (2) Amount and complexity of data to be reviewed and analyzed, (3) Risk of complications, morbidity, or mortality. Two of three MDM elements must meet or exceed the requirements for a given level. Time-based coding counts the total time on the date of the encounter, including face-to-face and non-face-to-face activities like documentation, care coordination, and order review.

HCPCS Level II codes cover supplies, equipment, and drugs not in CPT — required for Medicare/Medicaid billing.

HCPCS Level II codes are alphanumeric codes (beginning with letters A-V) that identify products, supplies, and services not covered by CPT codes. They are used for: (1) Durable medical equipment (DME) — E codes (e.g., E0114 for crutches); (2) Injectable drugs — J codes (e.g., J1745 for infliximab); (3) Ambulance services — A codes; (4) Orthotics and prosthetics — L codes; (5) Temporary codes — G codes for CMS-specific services; (6) Vision/hearing services — V codes. HCPCS codes are required for Medicare and Medicaid billing and are increasingly used by commercial payers.

Pediatric coding varies by age with specific codes for newborns, neonatal/pediatric critical care, and well visits.

Pediatric E/M coding has several age-specific considerations: (1) Newborn care uses codes 99460-99463 for initial and subsequent hospital care; (2) Neonatal critical care uses 99468-99469 for initial and 99471-99472 for subsequent days; (3) Pediatric critical care uses 99475-99476; (4) Well-child visits have age-specific codes (infant, 1-4, 5-11, 12-17); (5) Developmental screening (96110) and depression screening (96127) are commonly added to preventive visits. Time-based coding may be particularly relevant for complex pediatric cases with parent counseling.

Use modifier -25 when a significant, separately identifiable E/M service is performed alongside a procedure.

Modifier -25 should be used when a significant, separately identifiable E/M service is performed on the same day as a minor procedure or other service. The E/M service must be above and beyond the usual pre-operative and post-operative care associated with the procedure. Common family medicine scenarios include: performing a skin biopsy during an office visit for an unrelated complaint, administering injections during a visit for a separate medical condition, or addressing a new problem during a visit primarily for a procedure. Documentation must clearly support both services.

Code cardiac cath based on type (left/right/combined), angiography, and any interventions performed.

Cardiac catheterization coding requires careful attention to the type of catheterization (left heart, right heart, or combined), whether coronary angiography was performed, and whether any interventions were done. CPT 93451 is used for right heart catheterization, 93452 for left heart catheterization with ventriculography, 93453 for combined right and left. If percutaneous coronary intervention (PCI) is performed, additional codes from the 92920-92944 range apply. Always code injection procedures and imaging supervision separately when appropriate.

Essential orthopedic modifiers include LT/RT, 50, 59, 25, 57, 78, 79, and 22 for accurate billing.

Key orthopedic modifiers include: -LT/-RT (left/right side), -50 (bilateral procedure), -59 (distinct procedural service), -25 (significant separate E/M service), -57 (decision for surgery), -78 (return to OR for complication), -79 (unrelated procedure during post-op period), -76 (repeat procedure by same physician), -22 (increased procedural service), and -62 (two surgeons). Laterality modifiers are especially critical in orthopedics to prevent claim denials and ensure accurate documentation.

Multi-level spine coding: Decompression 63047 + 63048 (add-on). Fusion 22612/22558 + 22614/22585 (add-on by level). Interbody 22630 + 22632. Instrumentation 22840-22853. Decompression and fusion at same level both billable. Document each level specifically.

Multi-level spine surgery coding: **Posterior Decompression:** 63047 (laminectomy, single segment — lumbar), 63048 (each additional segment). **Posterior Fusion:** 22612 (lumbar, single segment), 22614 (each additional segment). **Anterior Fusion:** 22558 (lumbar, single segment), 22585 (each additional segment). **Interbody Fusion:** 22630 (posterior lumbar interbody fusion, PLIF), 22632 (each additional level). **Instrumentation:** 22840 (posterior non-segmental), 22842 (posterior segmental), 22853 (interbody device, each interspace). **Bone Graft:** 20930 (allograft morselized), 20931 (allograft structural), 20936 (autograft local). **Key Rules:** When decompression and fusion are performed at the same level, both are billable — they are not bundled. Each additional level uses add-on codes. Bilateral procedures use modifier 50. **Documentation:** Operative report must specify each level treated, approach, specific procedures at each level, and all hardware placed with sizes.

Code implants in phases: surgical placement (D6010), abutment (D6056/D6057), and implant crown (D6058-D6060).

Dental implant coding involves multiple phases: (1) Surgical placement - D6010 (endosteal implant), D6040 (eposteal implant); (2) Abutment - D6056 (prefabricated abutment), D6057 (custom abutment); (3) Crown - D6058 (abutment-supported porcelain/ceramic crown), D6059 (abutment-supported PFM crown), D6060 (abutment-supported metal crown); (4) Additional procedures may include D6104 (bone graft for implant), D7953 (bone graft, autogenous), and D4266 (guided tissue regeneration). Each phase should be billed on the date the specific service is performed.

Key urology codes: Cystoscopy 52000-52240, prostate biopsy 55700, robotic prostatectomy 55866, TURP 52601, ureteroscopy with lithotripsy 52352, ESWL 50590, vasectomy 55250. Use modifier 50 for bilateral procedures.

Common urology CPT codes: **Cystoscopy:** 52000 (diagnostic), 52204 (with biopsy), 52214 (with fulguration), 52235 (with bladder tumor resection <2.5cm), 52240 (>2.5cm). **Prostate:** 55700 (prostate biopsy), 55866 (robotic-assisted laparoscopic prostatectomy), 52601 (TURP). **Kidney/Ureter:** 50060 (nephrolithotomy), 52352 (ureteroscopy with lithotripsy), 50590 (ESWL). **Office Procedures:** 51798 (post-void residual ultrasound), 76857 (pelvic ultrasound limited), 51700-51703 (bladder irrigation/instillation). **Vasectomy:** 55250. **Key modifiers:** 50 (bilateral), 58 (staged procedure during global period), 78 (return to OR for complication), TC/26 (technical/professional components for imaging). Documentation must specify laterality, technique, and findings for each procedure.

The 8-minute rule: 8-22 min = 1 unit, 23-37 min = 2 units, 38-52 min = 3 units. Under 8 minutes of a single code = 0 units. Total all timed codes to determine total billable units, then allocate to highest-time codes first.

The 8-minute rule determines how many units of a timed CPT code can be billed per treatment session. Each timed code (97110, 97112, 97116, 97140, 97530, 97535, 97542, 97750) represents one 15-minute unit. The rule works as follows: 8-22 minutes = 1 unit, 23-37 minutes = 2 units, 38-52 minutes = 3 units, 53-67 minutes = 4 units. For mixed timed and untimed services, total the minutes of all timed codes, then divide. The key error: billing 7 minutes of a service as 1 unit — anything under 8 minutes of a single timed code cannot be billed as a unit. Additionally, when multiple timed codes are performed, you must use the total time across all timed codes to determine the total units, then allocate units to the codes that received the most time first. Incorrect application of this rule is one of the top reasons for PT claim underpayment.

Sinus surgery codes: FESS 31254-31288 by sinus location, septoplasty 30520, turbinate reduction 30140/30801-30802, balloon sinuplasty 31295-31297, image guidance 61782 (add-on). Diagnostic endoscopy 31231 bundles into surgical codes.

Key ENT sinus and nasal procedure codes: **Nasal Endoscopy:** 31231 (diagnostic), 31237 (with biopsy), 31238 (with control of epistaxis). **Functional Endoscopic Sinus Surgery (FESS):** 31254 (partial ethmoidectomy), 31255 (total ethmoidectomy), 31256 (maxillary antrostomy), 31267 (frontal sinus exploration), 31276 (frontal sinusotomy), 31287 (sphenoidotomy), 31288 (sphenoidotomy with tissue removal). **Septoplasty:** 30520. **Turbinate Reduction:** 30140 (submucous resection), 30801-30802 (ablation). **Image Guidance:** 61782 (add-on for stereotactic navigation). **Balloon Sinuplasty:** 31295-31297 (maxillary, frontal, sphenoid). **Critical Rule:** When multiple sinus procedures are performed bilaterally, use modifier 50 and sequence by highest RVU. Bundling rules require that diagnostic endoscopy (31231) is included in surgical endoscopy codes and cannot be billed separately.

Chemo administration: 96413 (first drug, first hour), 96415 (additional hours), 96417 (additional sequential drug), 96409/96411 (IV push). Hierarchy: chemo > therapeutic > hydration. First hour hydration bundles into chemo infusion.

Chemotherapy administration coding uses a hierarchical system: **Initial Drug, First Hour:** 96413 (IV infusion, first substance/drug, up to 1 hour). **Additional Hours, Same Drug:** 96415 (each additional hour beyond the first — requires >30 minutes beyond the prior hour). **Additional Sequential Drug:** 96417 (IV infusion, each additional sequential infusion of a new substance, up to 1 hour). **IV Push:** 96409 (first substance), 96411 (each additional substance). **Concurrent Infusion:** 96368 (used only when two drugs run simultaneously through the same line). **Hydration:** 96360 (first hour, only when it is the primary service), 96361 (each additional hour). **Critical sequencing rule:** Chemotherapy codes take hierarchy over therapeutic drug infusion codes, which take hierarchy over hydration codes. When chemotherapy is administered, hydration cannot be reported separately for the first hour — only additional hydration time beyond the first hour is billable.

Dialysis MCP codes: 90960 (4+ visits/month), 90961 (2-3 visits), 90962 (1 visit). First 3 months use transitional codes 90967-90970 at higher rates. Hospitalization requires prorated MCP plus separate inpatient E/M. Phone calls are included in MCP.

Medicare Monthly Capitated Payment (MCP) for ESRD: **90960:** 4+ face-to-face visits per month — highest reimbursement (~$240). **90961:** 2-3 face-to-face visits per month (~$190). **90962:** 1 face-to-face visit per month (~$135). **90966-90970:** Home dialysis MCP codes with similar visit tiers. **Key Rules:** Each visit must be documented with a face-to-face encounter note showing medical decision-making. Phone calls and non-face-to-face care coordination are included in the MCP — not separately billable. For the first 3 months of dialysis, use 90967-90970 (transitional codes) at higher rates because initial management is more complex. If a patient hospitalizes mid-month, prorate the MCP based on outpatient days and bill hospital E/M codes separately for inpatient days. Modifier 25 is not used with MCP codes — they are inherently complete service codes.

Joint injection codes: 20610 (major), 20605 (intermediate), 20600 (small joints). Modifier 59/XS for multiple sites. Add 76942 for ultrasound guidance. Bill drug separately (J1030, J3301). E/M with modifier 25 only for separately identifiable service.

Joint injection coding: **Major Joints (20610):** Shoulder, hip, knee, ankle — includes aspiration and/or injection. **Intermediate Joints (20605):** Wrist, elbow, AC joint. **Small Joints (20600):** Fingers, toes, trigger points. **Multiple Joints:** Use modifier 59/XS for each additional anatomic site. **Tendon Sheath Injection (20550):** For tendinitis/tenosynovitis. **Trigger Point Injection (20552-20553):** 20552 for 1-2 muscles, 20553 for 3+ muscles. **Ultrasound Guidance:** 76942 — separately billable when documented with permanent image storage. **Drug Billing:** Bill the injected medication separately (e.g., J1030 for methylprednisolone 40mg, J1040 for 80mg, J3301 for triamcinolone 10mg, J3300 for triamcinolone per 1mg). **Key Rule:** Do not bill E/M (modifier 25) with injections unless there is a separately identifiable evaluation and management service documented — a brief assessment to determine the injection site is included in the injection code.

PFT codes: 94010 (spirometry), 94060 (pre/post bronchodilator), 94726 (lung volumes), 94729 (DLCO), 94070 (bronchoprovocation), 94621 (cardiopulmonary exercise). Bill global in-office or modifier 26 for interpretation only.

PFT coding: **Spirometry:** 94010 (pre-bronchodilator), 94060 (pre- and post-bronchodilator — includes 94010, do not bill both). **Lung Volumes:** 94726 (plethysmography or gas dilution). **DLCO:** 94729 (diffusing capacity). **Complete PFT:** Bill 94010 or 94060 + 94726 + 94729 for a complete study. **Bronchoprovocation:** 94070 (methacholine or histamine challenge — includes baseline and post-challenge spirometry). **Cardiopulmonary Exercise Testing:** 94621 (comprehensive). **Pulse Oximetry:** 94760 (single), 94761 (multiple), 94762 (overnight or continuous). **Flow-Volume Loop:** Included in 94010/94060 — not separately billable. **Interpretation:** Professional component (modifier 26) includes the physician's written interpretation. Technical component (modifier TC) includes the equipment and technician. **Key Rule:** When PFTs are performed in the physician office by the physician's own equipment and staff, bill global (no modifier). When interpreting studies performed at another facility, bill modifier 26 only.

Cataract surgery: 66984 (standard phaco + IOL), 66982 (complex). IOL: V2632 (standard), V2787 (premium/toric/multifocal — patient upgrade cost). 90-day global period. YAG capsulotomy 66821 billable after global. Bilateral use modifier 50 or RT/LT.

Cataract surgery coding: **Procedure:** 66984 (extracapsular cataract removal with IOL insertion — standard phacoemulsification). 66982 (complex cataract requiring devices or techniques beyond standard). **IOL:** V2632 (standard monofocal IOL — included in facility fee for ASC). V2787 (premium IOL — toric, multifocal, accommodating — patient pays the upgrade cost). **Bilateral:** Use modifier 50 or RT/LT depending on payer preference. Most payers apply 150% reimbursement for bilateral same-day. **Femtosecond Laser-Assisted:** No separate CPT code — the laser component is not separately reimbursable by most payers; often patient-pay. **Global Period:** 90-day global includes pre-op H&P (day before or day of), surgery, and all routine post-operative visits. Post-op complications requiring return to OR use modifier 78. **YAG Capsulotomy:** 66821 — separately billable after global period ends if posterior capsule opacification develops.

Epidural injection codes: Interlaminar 62320-62323 (by level, +/- imaging). Transforaminal 64479-64484 (by level, imaging included). Bill fluoroscopy 77003 only with interlaminar approach. Document exact spinal level, approach, and imaging confirmation.

Epidural steroid injection coding by approach and level: **Interlaminar Approach:** 62320 (cervical/thoracic, without imaging), 62321 (cervical/thoracic, with imaging), 62322 (lumbar/sacral, without imaging), 62323 (lumbar/sacral, with imaging). **Transforaminal Approach:** 64479 (cervical/thoracic, first level), 64480 (each additional level), 64483 (lumbar/sacral, first level), 64484 (each additional level). **Imaging Guidance:** 77003 (fluoroscopic guidance — separately billable with interlaminar approach but included in transforaminal codes). **Drug Billing:** Bill injected medication separately (J1030/J1040 for methylprednisolone, J3301/J3300 for triamcinolone, J1094 for dexamethasone). **Key Rule:** Transforaminal epidurals have imaging guidance included in the code — do not bill 77003 separately. Interlaminar epidurals can bill 77003 separately when fluoroscopy is used. **Documentation:** Must include specific spinal level, approach, needle placement confirmation by imaging, and medication type/dose.

Skin testing: 95004 (percutaneous per test, 40-80/session), 95024 (intradermal per test), 95044 (patch per test). In-vitro: 86003 (specific IgE per allergen), 86005 (panel). Do not bill skin and blood testing for same allergen same day.

Allergy skin testing codes: **Percutaneous (Prick/Scratch) Testing:** 95004 — billed per test, includes application and reading. Typically 40-80 tests per session covering environmental, food, and venom allergens. **Intradermal Testing:** 95024 (sequential and incremental) — billed per test, used for confirmation when percutaneous test is negative but clinical suspicion remains. 95027 (airborne allergens) — for specific inhalant allergen intradermal testing. **Patch Testing:** 95044 — per test, for contact dermatitis evaluation. Application visit and 48-hour/96-hour reading visits are separately billable E/M encounters. **In-Vitro Testing:** 86003 (allergen-specific IgE, per allergen) — blood test alternative. 86005 (multi-allergen panel screen). **Key Rules:** Do not bill 95004 and 86003 for the same allergen on the same date — choose one method per allergen. Skin testing requires direct physician supervision. Each test unit = one allergen extract applied. Document the number of tests, allergens tested, and results for each.

Diabetes coding: E/M 99214-99215, CCM 99490/99491, CGM professional 95249-95251, remote monitoring 98975-98981, A1C 83036/83037. Insulin pump via DME channel (E0784). Document complexity of decision-making for level 4-5 visits.

Diabetes management coding: **E/M Visits:** Most diabetes follow-ups support 99214-99215 based on medical decision-making complexity (insulin adjustment, complication management, A1C review). **Chronic Care Management:** 99490 (first 20 minutes of clinical staff time per month), 99491 (first 30 minutes of physician time per month) — for coordinating diabetes care between visits. **CGM Professional:** 95249 (patient-provided equipment sensor placement and training), 95250 (sensor placement for physician-owned equipment, up to 72 hours), 95251 (interpretation and report of CGM data, minimum 72 hours). **Remote Therapeutic Monitoring:** 98975 (initial setup), 98977 (device supply, 30-day period), 98980/98981 (treatment management services, first 20 min / additional 20 min). **Insulin Pump:** E0784 (external insulin pump), A9274 (pump supplies) — typically billed through DME channel. **A1C Testing:** 83036 (in-office point-of-care), 83037 (when performed by CLIA-waived device). **Diabetic Foot Exam:** Included in standard E/M — document monofilament testing and pedal pulses.

Global OB codes: 59400 (vaginal), 59510 (cesarean), 59610 (VBAC), 59618 (repeat cesarean). Includes all routine antepartum (13 visits), delivery, and 6-week postpartum. Excludes labs, ultrasounds, NSTs, and complications. Unbundle with 59425/59426 for partial care.

Global OB package codes: **59400:** Routine obstetric care including antepartum, vaginal delivery, and postpartum care. **59510:** Routine OB care including antepartum, cesarean delivery, and postpartum care. **59610:** Routine OB care after previous cesarean, vaginal delivery (VBAC). **59618:** Routine OB care after previous cesarean, repeat cesarean. **What is INCLUDED:** All routine antepartum visits (typically 13 visits), admission to hospital for delivery, delivery (vaginal or cesarean), postpartum care for 6 weeks. **What is NOT included:** Initial pregnancy confirmation visit (separately billable E/M), lab work and diagnostic testing, ultrasounds (76801-76819), non-stress tests (59025), amniocentesis (59000), complications requiring hospitalization before delivery, epidural management (by anesthesiologist). **Unbundling Rules:** If <4 antepartum visits: bill per-visit E/M. 4-6 visits: 59425. 7+ visits: 59426. Delivery only: 59409/59514/59612/59620.

Colonoscopy polypectomy: 45385 (snare), 45388 (ablation), 45380 (biopsy), 45390 (EMR). Screening converts to diagnostic with polyp — use modifier PT to preserve screening benefit. Multiple techniques at different sites: bill each with modifier 59.

Colonoscopy polypectomy coding: **Screening Colonoscopy:** G0121 (average risk), G0105 (high risk). If a polyp is found and removed, the screening converts to a diagnostic procedure — use the appropriate removal code with modifier PT (colorectal cancer screening). **Polypectomy by Technique:** 45385 (snare polypectomy), 45388 (ablation/fulguration), 45384 (hot biopsy forceps removal — less common). **Cold Forceps Biopsy:** 45380 (biopsy, single or multiple). **EMR (Endoscopic Mucosal Resection):** 45390 (for flat/sessile lesions). **Multiple Polyps, Same Technique:** Bill the primary code once — additional polyps removed by the same technique are included. **Multiple Polyps, Different Techniques:** Bill each technique code separately — e.g., 45385 (snare) + 45380 (biopsy) at different sites. **Key Rule:** Modifier PT preserves the screening benefit for the patient when a screening colonoscopy converts to diagnostic due to polyp finding — without PT, the patient may owe a copay. **Modifier 59:** Used when distinct polypectomy techniques are performed at clearly different anatomic sites.

CMT codes: 98940 (1-2 regions), 98941 (3-4 regions), 98942 (5 regions), 98943 (extraspinal — not Medicare-covered). One CMT code per visit. E/M with CMT requires modifier 25 and separately identifiable evaluation. Document each region treated.

CMT coding: **98940:** Spinal manipulation, 1-2 regions. **98941:** Spinal manipulation, 3-4 regions. **98942:** Spinal manipulation, 5 regions. **Spinal Regions Defined:** Cervical (including atlanto-occipital), thoracic, lumbar, sacral, pelvic/sacroiliac. **Extraspinal CMT:** 98943 — manipulation of extraspinal regions (head, lower/upper extremities, rib cage, abdomen). Note: Medicare does not cover 98943. **E/M with CMT:** E/M codes (99202-99215) can be billed with CMT using modifier 25 when a separately identifiable evaluation is performed and documented — common on initial visits and re-evaluations. **Key Rules:** Only one CMT code per visit (based on total regions treated). Count each region only once regardless of technique used. Document each region treated with pre- and post-treatment findings. The number of regions must match the code — billing 98942 (5 regions) requires documentation of treatment to all 5 spinal regions.

Reconstructive (covered): restores function from trauma, disease, or congenital defect with documentation. Cosmetic (patient-pay): appearance-only improvement. Gray areas (rhinoplasty, abdominoplasty, blepharoplasty) require functional impairment documentation with objective testing.

Reconstructive vs cosmetic determination: **Reconstructive (Insurance-Covered):** Restores body structure or function impaired by congenital defect, trauma, infection, disease, or prior surgery. Examples: breast reconstruction after mastectomy (19357-19369), cleft lip/palate repair (40700-40761), skin grafts for burns (15100-15278), nasal reconstruction after skin cancer excision, blepharoplasty when eyelid drooping obstructs vision (documented by visual field testing showing >30% superior field loss). **Cosmetic (Patient-Pay):** Reshaping normal structures solely to improve appearance. Examples: rhinoplasty without functional obstruction, facelift, abdominoplasty without hernia or functional panniculitis, breast augmentation without reconstruction indication. **Gray Areas Requiring Documentation:** Rhinoplasty — reconstructive if correcting nasal obstruction or post-trauma deformity (document with CT scan, nasal endoscopy, or functional testing). Abdominoplasty — reconstructive if panniculitis causes recurrent infections (document treatment history, photographs). Blepharoplasty — reconstructive with visual field testing showing functional impairment.

CT/MRI coding: each body part has three options — without contrast, with contrast, without-then-with contrast. Never combine without + with codes instead of using the combined code. Document contrast type, volume, route, and clinical indication.

CT and MRI contrast coding: **CT Without Contrast:** 70450 (head), 71250 (chest), 74150 (abdomen), 72131 (lumbar spine). **CT With Contrast:** 70460 (head), 71260 (chest), 74160 (abdomen), 72132 (lumbar). **CT Without Then With Contrast:** 70470 (head), 71270 (chest), 74170 (abdomen), 72133 (lumbar). **MRI Without Contrast:** 70551 (brain), 71550 (chest), 74181 (abdomen), 72148 (lumbar). **MRI With Contrast:** 70552 (brain), 72149 (lumbar). **MRI Without Then With Contrast:** 70553 (brain), 71552 (chest), 74183 (abdomen), 72158 (lumbar). **Key Rule:** The with/without contrast study is the most comprehensive and cannot be billed by combining the without and the with codes separately — it is a single code with a single global fee. **Documentation:** Must specify contrast agent type, volume, route of administration, and clinical indication for contrast. Allergy pre-medication must be documented when applicable.

Medicare covers routine foot care only with qualifying systemic conditions (diabetes with neuropathy, PVD). Use modifier Q7 (1 condition), Q8 (2), Q9 (3+). Document class findings (A-amputation, B-absent pulses, C-neuropathy) and medical necessity.

Medicare routine foot care coverage: **Not Covered (Default):** Cutting/removing corns, calluses, trimming nails, and other hygienic care are not covered as routine foot care. **Covered with Qualifying Conditions:** Routine foot care becomes covered when the patient has a systemic condition that creates a hazard if performed by a non-professional. **Qualifying Conditions:** Diabetes with peripheral neuropathy, peripheral vascular disease, chronic thrombophlebitis, peripheral neuropathy from other causes, arteriosclerosis obliterans. **Required Modifiers:** Q7 (one qualifying condition documented), Q8 (two conditions), Q9 (three or more conditions). **Class Findings (Must Document):** Class A — non-traumatic amputation. Class B — absent pedal pulses. Class C — peripheral neuropathy with loss of protective sensation. **Documentation:** Must document the qualifying systemic condition, class finding (A, B, or C), and medical necessity for professional foot care. Without this documentation and the Q modifier, claims are denied as routine/non-covered.

Procedure + E/M coding: wound repair (12001-13160), I&D (10060-10061), splints (29105-29515), foreign body (10120-10121), POCT (87880, 87804, 81002). All require modifier 25 on E/M with separately documented evaluation beyond procedure decision.

Urgent care procedure + E/M coding: **Wound Repair:** Simple (12001-12021 by length and location), intermediate (12031-12057), complex (13100-13160) — all separately billable with E/M using modifier 25. **Incision and Drainage:** 10060 (simple I&D), 10061 (complicated I&D) — billable with E/M and modifier 25. **Splinting/Casting:** 29105-29515 (by body part) — billable with E/M. **Foreign Body Removal:** 10120 (simple, subcutaneous), 10121 (complicated) — separately billable. **Point-of-Care Testing:** 87880 (rapid strep), 87804 (rapid flu), 81002 (UA dipstick), 85018 (hemoglobin), 36415 (venipuncture). **X-Ray:** 73030 (shoulder), 73110 (wrist), 73600 (ankle), 73630 (foot) — bill professional (26) and technical components. **Key Rule:** Every procedure billed with E/M requires modifier 25 on the E/M code and documentation of a separately identifiable evaluation and management service. The E/M must document more than just the decision to perform the procedure.

Anesthesia time: start (pre-anesthesia prep in OR) to end (PACU transfer). 1 unit per 15 minutes (most payers). Formula: (base units + time units + modifier units) × conversion factor. Document start/stop times, drugs, and monitoring on anesthesia record.

Anesthesia time calculation: **Start Time:** When the anesthesiologist begins preparing the patient for anesthesia (pre-anesthesia evaluation in the OR, line placement, induction). **End Time:** When the anesthesiologist transfers care to the PACU team or the patient is safely transferred. **Time Units:** Most payers: 1 unit per 15 minutes. Medicare: 1 unit per 15 minutes. Some commercial payers: 1 unit per 10 minutes — verify by contract. **Calculation:** Actual minutes ÷ 15 = time units (round to nearest tenth or per payer rules). Example: 90-minute case = 6 time units. **Total Formula:** (Base units + time units + modifier units) × conversion factor. Example: Knee replacement (01402) = 7 base units + 6 time units (90 min) + 1 P3 modifier unit = 14 units × $22.00 CF = $308.00. **Concurrent Cases:** When medically directing 2 CRNAs, the anesthesiologist bills reduced time for each case (varies by payer). **Documentation:** Anesthesia record must document start/stop times, drugs administered, monitoring data, and events.

Bill panel code when all component tests are performed (e.g., 80053 CMP = 14 tests). Bill individual components only when partial panel is ordered. Unbundling a complete panel into components is fraud. Revenue difference is 25-40% — know your payer contracts.

Panel vs component decision: **Bill Panel When:** All tests in the panel definition are performed. Example: CMP (80053) includes 14 tests — if all 14 are run, bill 80053. Reimbursement is typically lower per test but guaranteed as one claim. **Bill Components When:** Only some tests from the panel are ordered, or when additional individual tests are ordered beyond the panel. Example: If a physician orders only BMP (80048) instead of full CMP, bill 80048. **Key Panels:** 80048 (BMP, 8 tests), 80050 (general health panel), 80053 (CMP, 14 tests), 80061 (lipid panel), 80076 (hepatic function panel). **Revenue Impact:** Billing CMP components individually instead of 80053 can reimburse 25-40% more in some cases — but this is only appropriate when the tests are truly ordered individually, not as a panel. Unbundling a panel into components when the panel was ordered is considered fraud. **Payer-Specific Rules:** Some commercial payers reimburse panels differently than Medicare — know your contracts.

Lung surgery codes: lobectomy 32480/32663(VATS), pneumonectomy 32440, wedge 32505/32666(VATS), segmentectomy 32484/32669. Esophagectomy 43107-43117. VATS and open have different codes. Conversion reports open code only.

Lung surgery codes: **Lobectomy:** 32480 (open), 32663 (VATS lobectomy — thoracoscopic). **Pneumonectomy:** 32440 (total pneumonectomy), 32442 (completion pneumonectomy). **Wedge Resection:** 32505 (open), 32666 (VATS). **Segmentectomy:** 32484 (open), 32669 (VATS). **Diagnostic Thoracoscopy:** 32601 (diagnostic with biopsy). **Pleural Procedures:** 32650 (pleurodesis), 32651 (thoracoscopic decortication), 32652 (open decortication). **Mediastinoscopy:** 39401 (with biopsy). **Esophagectomy:** 43107 (distal), 43108 (total), 43112 (transthoracic), 43117 (partial with reconstruction). **Key Rules:** VATS codes reimburse differently from open codes — do not bill the open code for a VATS approach. Conversion from VATS to open requires reporting the open code (not both). Bilateral thoracoscopic procedures use modifier 50. Separately bill chest tube placement (32551) only when not related to the surgical procedure.

Fracture coding: closed without manipulation (lower value), closed with manipulation (moderate), ORIF (highest value). Global periods: 90-day for surgical, 0-10 day for non-surgical. Initial x-rays and implant hardware are separately billable.

Fracture care coding: **Closed Treatment (No Manipulation):** Codes like 25600 (distal radius), 27500 (femoral shaft), 27750 (tibial shaft) — includes application of initial cast/splint. **Closed Treatment with Manipulation:** Higher-value codes like 25605 (distal radius with manipulation), 27502 (femoral shaft with manipulation). **Open Treatment (ORIF):** Surgical fixation codes like 25607-25609 (distal radius ORIF), 27236 (femoral neck ORIF), 27759 (tibial shaft ORIF). **Global Period:** Fracture care codes include a 90-day global for surgical treatment and typically 0 or 10-day globals for non-surgical treatment. Follow-up visits, cast changes, and x-rays during the global period are included. **Separately Billable:** Initial x-rays on the day of injury, surgical hardware (implant HCPCS codes), and complications requiring return to OR (modifier 78). **Documentation:** Must specify fracture type (open/closed), location, treatment approach, and reduction method.

Vaccine coding: 90460 + 90461 per component (with counseling, under 19). 90471 + 90472 per injection (without counseling). Each vaccine has its own product code. VFC patients: bill administration only, not vaccine product. Document counseling for 90460.

Pediatric vaccine coding: **Under Age 19 with Counseling:** 90460 (first component of each vaccine administered with counseling), 90461 (each additional component). Example: DTaP = 90460 + 90461×2 (3 components). MMR = 90460 + 90461×2 (3 components). **Without Counseling or Age 19+:** 90471 (first injection), 90472 (each additional injection). **Oral/Intranasal:** 90473 (first), 90474 (each additional). **Vaccine Product Codes:** Each vaccine has its own CPT code (90707 MMR, 90713 IPV, 90716 Varicella, 90681 Rotavirus, 90670 PCV13, etc.). **VFC Rules:** For VFC-eligible patients, bill the administration code to Medicaid/payer but do NOT bill the vaccine product code — the vaccine is provided free by the federal program. **Key Rule:** Use 90460/90461 only when the physician or qualified healthcare professional provides face-to-face counseling about the vaccine to the patient/parent. Without documented counseling, use 90471/90472.

Pathology levels: I (88300) gross only, II (88302) simple, III (88304) low complexity, IV (88305) most common (skin/colon biopsies), V (88307) high (lobectomies), VI (88309) highest (bone marrow). Level determined by tissue type. Bill per specimen.

Surgical pathology levels: **Level I (88300):** Gross examination only. Example: teeth, fingernails. **Level II (88302):** Gross and microscopic examination. Example: appendix (incidental), hernia sac. **Level III (88304):** Low complexity. Example: gallbladder, uterus (prolapse), skin (excision of cyst). **Level IV (88305):** Moderate complexity. Most common level — includes skin biopsies, colon biopsies, thyroid lobectomy, lymph node biopsy, prostate needle biopsy, cervical biopsy. **Level V (88307):** High complexity. Example: lung lobectomy, kidney (partial/total nephrectomy), uterus with tumor, liver biopsy (not needle). **Level VI (88309):** Highest complexity. Example: bone marrow biopsy with cellularity assessment, fetal organs, exenteration specimens. **Key Rule:** The level is determined by the tissue type received, not the clinical diagnosis. Each specimen is billed separately at its appropriate level. A case with 3 skin biopsies = 3 units of 88305.

Bill insurance for routine/standard care costs. Bill sponsor for investigational items, extra protocol tests, and research activities. Append Z00.6 as secondary diagnosis. Complete coverage analysis before enrollment. Incorrect billing direction constitutes fraud.

Clinical trial billing separation (coverage analysis): **Billable to Insurance:** Routine care costs that would occur regardless of trial participation — office visits, standard lab work, imaging for disease monitoring, treatment of side effects, and conventional care. Medicare specifically covers items/services provided absent a clinical trial, services required for administration/monitoring of investigational items, and treatment of complications. **Billable to Sponsor:** Investigational drugs/devices, protocol-required extra tests, research coordinator time, extra monitoring visits beyond standard of care, data collection activities, and adverse event reporting. **Gray Areas:** Some tests serve both clinical and research purposes — the coverage analysis must determine the primary purpose. **Compliance Rule:** Billing insurance for research-only services is fraud. Billing sponsors for standard-of-care services increases trial costs unnecessarily. ICD-10 code Z00.6 must be appended as secondary diagnosis on all trial-related claims. The coverage analysis should be completed before patient enrollment and documented in a coverage analysis grid.

Occupational health codes: DOT physical 99456, drug screening 80305-80307, workers comp E/M with state fee schedule, audiometric testing 92552-92553, spirometry 94010, impairment rating 99455-99456. Bill employer-direct services at contracted rates, WC at state fee schedule.

Occupational health coding: **DOT Physical:** 99456 (work disability examination by treating physician) or E/M code depending on payer — typically billed directly to employer at contracted rate. **Drug Screening:** 80305 (presumptive, any number of drug classes), 80306 (presumptive with instrument-assisted), 80307 (presumptive with instrument-assisted, per date). Confirmatory: 80320-80377 by drug class. **Workers Comp Initial Visit:** Use standard E/M codes (99201-99205 for new, 99211-99215 for established) with workers comp as primary payer. **Audiometric Testing:** 92552-92553 (pure tone audiometry) for OSHA hearing conservation programs. **Respiratory Fit Testing:** 94010 (spirometry) or specific fit testing codes billed to employer. **Impairment Rating:** 99456 (examination for work disability by treating physician), 99455 (examination for work disability by other physician). **Key Rule:** Workers comp fee schedules are state-specific and often exceed Medicare rates — bill at the state fee schedule, not Medicare rates.

Catheterization coding: bill highest selectivity per vascular family. First order (36215/36245), second (36216/36246), third (36217/36247), additional (36218/36248). Non-selective aorta (36200) bundles into selective codes. Each vascular family billed separately.

Selective catheterization coding: **Order of Selectivity:** First order — main branch of the aorta (e.g., left common carotid, celiac trunk, renal artery). Second order — branch of first order vessel (e.g., left internal carotid, hepatic artery). Third order and beyond — further branching vessels. **Coding Rules:** Bill the highest order of selectivity reached per vascular family. 36215 (selective first order thoracic/cervical), 36216 (second order), 36217 (third order), 36218 (additional second/third order). 36245 (selective first order abdominal/pelvic), 36246 (second order), 36247 (third order), 36248 (additional second/third order). **Separate Vascular Families:** Each distinct vascular family requires a separate catheterization code. If the catheter is placed in both the right and left renal arteries, bill for two separate first-order selections. **Bundling:** Non-selective catheterization (36200 abdominal aorta) is included in selective catheterization codes and should not be billed separately. **Documentation:** Specify the vessels catheterized, order achieved, and imaging findings.

Transfusion: 36430 per unit with typing (86900/86901) and crossmatch (86920). Bone marrow: 38220 (aspiration), 38221 (biopsy), 38222 (combined same-site). Flow cytometry: 88184 (first marker) + 88185 (each additional). Use 38222 for same-site aspiration + biopsy.

Blood transfusion and bone marrow coding: **Transfusion:** 36430 (transfusion of blood or blood components — includes monitoring, typically per unit). Some payers require reporting by product type: 86900 (ABO typing), 86901 (Rh typing), 86920 (compatibility testing). **Bone Marrow Aspiration:** 38220 — billed per procedure regardless of number of aspiration attempts. **Bone Marrow Biopsy:** 38221 — can be billed with 38220 if aspiration and biopsy are performed at different sites (same site = 38222 for combined). **Combined Aspiration + Biopsy:** 38222 (when performed at the same site). **Bone Marrow Transplant:** 38240 (allogeneic), 38241 (autologous). **Flow Cytometry:** 88184 (first marker), 88185 (each additional marker — typically 15-30 markers per panel). **Coagulation Studies:** 85610 (PT/INR), 85730 (PTT), 85379 (D-dimer). **Key Rule:** 38220 and 38221 should not be billed together when performed at the same site — use 38222 instead. Flow cytometry markers must be medically justified for each antibody tested.

ID consultation: 99252-99255 (initial), 99231-99233 (subsequent follow-up). Most ID consults support 99254-99255 complexity. Document requesting physician, clinical question, pathogen differential, and specific antibiotic recommendations. Some payers require initial hospital care codes instead of consultation codes.

ID consultation billing: **Initial Inpatient Consultation:** 99252 (straightforward MDM), 99253 (low complexity), 99254 (moderate complexity), 99255 (high complexity). Most ID consultations support 99254-99255 due to complex antibiotic selection, resistance pattern analysis, and multi-system involvement. **Subsequent Hospital Care:** After the initial consultation, follow-up visits use subsequent hospital care codes (99231-99233). **Documentation Requirements:** (1) Request for consultation from the attending physician, (2) Clinical question being addressed, (3) Detailed history and exam specific to the infectious condition, (4) Assessment with differential diagnosis of potential pathogens, (5) Specific recommendations including antibiotic selection, dosing, monitoring, and treatment duration. **Key Rule:** Some payers (including Medicare) no longer recognize consultation codes — bill initial hospital care (99221-99223) instead, with appropriate documentation of the AI modifier in some jurisdictions. **Time-Based Billing:** Prolonged service codes (99356-99357) can be added when total floor time exceeds threshold for the selected consultation level.

Key DME codes: wheelchairs K0001-K0823, hospital beds E0260-E0265, oxygen E1390/E0431, CPAP E0601, BiPAP E0470-E0471, walkers E0130-E0143, orthotics L3000 series, diabetic shoes A5500. All require qualifying diagnosis and physician order.

Common DME HCPCS codes: **Wheelchairs:** K0001 (standard manual), K0004 (high-strength lightweight), K0823 (power wheelchair group 2). **Hospital Beds:** E0260 (semi-electric), E0265 (total electric). **Oxygen Equipment:** E1390 (portable gaseous O2 system), E0431 (stationary concentrator), E0433 (portable concentrator). **CPAP/BiPAP:** E0601 (CPAP), E0470 (BiPAP without backup rate), E0471 (BiPAP with backup rate). **Walking Aids:** E0105 (cane, quad), E0130 (walker, rigid), E0143 (walker with wheels). **Orthotic Devices:** L3000-L3999 (foot orthotics), L1832-L1844 (knee orthoses). **Diabetic Shoes:** A5500 (diabetic shoe pair), A5501 (custom shoe), A5503-A5513 (inserts). **Key Rules:** DME must meet the definition: durable, used for medical purposes, appropriate for home use, and useful only for an individual who is ill or injured. Each item requires a qualifying diagnosis and physician order.

Pharmacy adjudication: real-time PBM processing using NCPDP format with BIN/PCN/NDC. Pricing via AWP-%, MAC, or NADAC formulas. Formulary tiers determine copays. Common rejects: 75 (prior auth), 76 (plan limits), 79 (refill too soon), 70 (not covered).

Pharmacy claims adjudication: **Real-Time Processing:** Unlike medical claims, pharmacy claims are adjudicated in real-time at the point of sale through PBM switches (SureScripts, Relay Health). **NCPDP Format:** Claims use National Council for Prescription Drug Programs (NCPDP) format, not CMS-1500 or UB-04. **Key Claim Fields:** BIN (bank identification number), PCN (processor control number), group number, member ID, NDC (11-digit drug code), quantity dispensed, days supply, DAW (dispense as written) code. **Pricing:** PBMs reimburse using formulas like AWP-%, MAC (Maximum Allowable Cost), or NADAC (National Average Drug Acquisition Cost). **Copay Tiers:** Formulary position determines patient copay: Tier 1 (generic, lowest copay), Tier 2 (preferred brand), Tier 3 (non-preferred brand), Tier 4 (specialty). **Reject Codes:** Common rejects include 75 (prior auth required), 76 (plan limitations exceeded), 79 (refill too soon), 70 (product/service not covered).

E/M coding: 99213 (moderate — self-limited problems), 99214 (moderate-high — chronic conditions with medication management), 99215 (high — severe exacerbation/life threat). Correct 99213→99214 coding recovers ~$40/visit. Document problems, data reviewed, and risk level.

E/M coding optimization for primary care: **2021 E/M Guidelines (Current):** E/M level is determined by either (1) medical decision-making complexity or (2) total time. Most primary care visits use MDM. **99213 (Moderate MDM):** 2+ self-limited problems, OR 1 chronic condition with mild exacerbation. Low amount/complexity of data. Low risk management. **99214 (Moderate-High MDM):** 1+ chronic condition with exacerbation, OR 2 or more chronic stable conditions requiring medication management. Moderate data (ordering/reviewing tests, requesting records). Moderate risk (prescription drug management). **99215 (High MDM):** Chronic condition with severe exacerbation, OR condition posing threat to life/function. Extensive data (independent interpretation of tests). High risk (hospitalization decision, drug requiring intensive monitoring). **Revenue Impact:** A practice seeing 25 patients/day that correctly codes 99214 instead of downcoding to 99213 gains approximately $40/visit × 25 = $1,000/day = $250,000/year. **Documentation Keys:** Document each problem addressed, data reviewed, and risk level for every visit.

ED E/M codes: 99281 (minimal), 99282 (low), 99283 (moderate), 99284 (high), 99285 (high with life threat). Critical care: 99291/99292. No new/established distinction. Document presenting problem severity and MDM complexity. Observation: 99218-99220.

ED E/M codes: **99281:** Minimal problem (self-limited, minor severity). **99282:** Low-moderate severity (e.g., minor laceration evaluation, UTI). **99283:** Moderate severity (e.g., asthma exacerbation, abdominal pain workup). **99284:** High severity without life/function threat (e.g., chest pain requiring workup, pneumonia with moderate complexity). **99285:** High severity with significant threat to life or physiologic function (e.g., STEMI, stroke, sepsis, major trauma). **Critical Care:** 99291 (first 30-74 minutes), 99292 (each additional 30 minutes) — used when the patient has a critical illness or injury that acutely impairs one or more vital organs. **Key Differences from Office E/M:** ED codes do not distinguish between new and established patients. ED codes require documentation of severity of presenting problem in addition to MDM complexity. ED E/M codes are evaluated based on both the nature of the presenting problem and the services performed. **Observation:** 99218-99220 (initial), 99224-99226 (subsequent), 99217 (discharge).

Geriatric codes: AWV G0438/G0439, cognitive assessment 99483, advance care planning 99497/99498, TCM 99495/99496, CCM 99490/99491, home visits 99341-99350. Systematic AWV + CCM + TCM generates $100-$200/patient/year in additional revenue.

Geriatric-specific codes: **Annual Wellness Visit:** G0438 (initial AWV, includes health risk assessment, advance directive review, personalized prevention plan). G0439 (subsequent AWV). **Cognitive Assessment:** 99483 (assessment and care planning for cognitive impairment — includes cognition-focused history, exam, functional assessment, and written care plan). **Advance Care Planning:** 99497 (first 30 minutes), 99498 (each additional 30 minutes) — billable separately from AWV and E/M. **Transitional Care Management:** 99495 (moderate complexity, face-to-face within 14 days of discharge), 99496 (high complexity, face-to-face within 7 days). **CCM:** 99490 (20+ min clinical staff time/month), 99491 (30+ min physician time/month). **Home Visits:** 99341-99345 (new patient), 99347-99350 (established patient) — by MDM complexity level. **Key Revenue Opportunity:** A geriatric practice implementing AWV + CCM + TCM systematically can generate $100-$200/patient/year in additional revenue beyond standard E/M visits.

OASIS reimbursement drivers: ADL functional scores (M1800-M1860), clinical grouping from diagnoses (M1021-M1023), comorbidity adjustments from secondary diagnoses, early vs late episode timing, and institutional vs community referral source. Accurate assessment is critical.

OASIS items driving reimbursement: **Functional Status:** M1800-M1860 (ADL scores — grooming, dressing, bathing, toileting, transferring, ambulation) directly influence the functional domain of the PDGM case-mix group. Higher functional impairment = higher payment. **Clinical Grouping:** M1021-M1023 (primary and secondary diagnoses) determine the clinical grouping (Musculoskeletal Rehab, Neuro Rehab, Wound, Complex Nursing, Behavioral Health, MMTA). **Comorbidity Adjustment:** Secondary diagnoses (M1023) can trigger comorbidity adjustments that increase the payment rate by 5-20%. **Timing:** Early vs late episode (first 30 days vs second 30 days) affects payment — early episodes pay more. **Referral Source:** Institutional (post-acute from hospital) vs community (from physician office) affects the payment tier. **Key Rule:** OASIS accuracy is critical — underrating functional limitations reduces the case-mix group and payment. Overrating is compliance fraud. Document actual patient status at time of assessment.

Sleep study codes: 95810 (in-lab PSG), 95811 (PSG with CPAP titration), 95800-95801 (home sleep test), 95805 (MSLT/MWT), 95803 (actigraphy). HST required before in-lab PSG. Split-night needs AHI ≥20 in first 2 hours.

Sleep study codes: **In-Lab Polysomnography (PSG):** 95810 (6+ hours, attended, sleep staging with 4+ additional parameters — respiratory, cardiac, oximetry, body position). 95811 (PSG with CPAP/BiPAP titration — split-night or full-night titration study). **Home Sleep Test (HST):** 95800 (unattended sleep study with airflow, respiratory effort, and blood oxygen), 95801 (unattended with airflow, respiratory effort, blood oxygen, and heart rate). **MSLT (Multiple Sleep Latency Test):** 95805 — for narcolepsy evaluation, performed the day after overnight PSG. Requires 4-5 nap opportunities at 2-hour intervals. **MWT (Maintenance of Wakefulness Test):** 95805 — same code as MSLT. **Actigraphy:** 95803 (actigraphy testing, recording, analysis, and interpretation — minimum 3 consecutive 24-hour periods). **Professional Interpretation:** Modifier 26 for physician interpretation of technically performed study. **Key Rule:** HST must be ordered before in-lab PSG for uncomplicated suspected OSA (most payers). Split-night (95811) requires documented AHI ≥20 in the first 2 hours of the diagnostic portion.

Selective (97597-97598): removing loose/non-viable tissue without cutting to specific depth. Surgical (11042-11044): excising to viable tissue at specific depth (skin, muscle, bone). Non-selective (97602): wet dressings/whirlpool. Document wound size, tissue types, and depth.

Debridement code selection: **Selective Debridement (Active Wound Care Management):** 97597 (first 20 sq cm) — removal of devitalized tissue using wet-to-dry dressings, enzymatic agents, autolytic methods, sharp selective removal of loose/non-viable tissue. 97598 (each additional 20 sq cm). Performed by any qualified healthcare professional. **Non-Selective Debridement:** 97602 — removal of devitalized tissue by methods such as wet-to-wet dressings or whirlpool. Lower reimbursement than selective. **Surgical Debridement (Excisional):** 11042 (skin/subcutaneous, first 20 sq cm), 11043 (muscle/fascia, first 20 sq cm), 11044 (bone, first 20 sq cm). Add-on codes: 11045, 11046, 11047 (each additional 20 sq cm by depth). Requires active excision to viable tissue with specific depth documentation. **Key Determination:** If the provider is removing tissue down to a specific viable tissue level (bleeding tissue), it is surgical debridement. If the provider is selectively removing loose/non-viable tissue without cutting to a specific depth, it is selective debridement. **Documentation:** Must include wound size (L × W × D), tissue types present, depth of debridement, and clinical judgment supporting the approach.

OT codes: evaluations 97165-97167, self-care training 97535, work reintegration 97537, wheelchair management 97542, cognitive intervention 97129-97130, sensory integration 97533, orthotic training 97760. Shared with PT: 97110, 97530, 97140, 97112.

OT-specific codes: **Evaluations:** 97165 (low complexity), 97166 (moderate complexity), 97167 (high complexity). **Re-evaluation:** 97168. **Self-Care/Home Management Training:** 97535 — training in self-care activities (feeding, dressing, bathing, grooming) and home management. Unique to OT scope. **Community/Work Reintegration:** 97537 — training in community/work reintegration activities. **Wheelchair Management:** 97542 — wheelchair management and propulsion training. **Shared Codes with PT:** 97110 (therapeutic exercise), 97530 (therapeutic activities), 97140 (manual therapy), 97112 (neuromuscular re-education). **Orthotic Management:** 97760 (orthotic management and training — initial encounter), 97761 (prosthetic training — initial encounter). **Cognitive Skills Development:** 97129 (first 15 minutes), 97130 (each additional 15 minutes) — cognitive function intervention including attention, memory, reasoning. **Sensory Integration:** 97533 — sensory integrative techniques for enhanced sensory processing. **Key Rule:** OT evaluations (97165-97167) are distinct from PT evaluations (97161-97163) — both can be performed and billed on the same day if medically justified.

Telehealth-eligible: E/M 99202-99215 (modifier 95), mental health 90791/90832-90847, CCM 99490/99491, RPM 99453-99458, telephone 99441-99443. Check CMS Telehealth Services List quarterly. Not eligible: hands-on exams, procedures.

Telemedicine-eligible codes: **E/M Visits:** 99202-99215 (office visits via audio-video with modifier 95 and POS 02/10). **Mental Health:** 90791 (psychiatric diagnostic evaluation), 90832-90838 (psychotherapy), 90839-90840 (crisis psychotherapy), 90846-90847 (family psychotherapy). **Chronic Care Management:** 99490/99491 (inherently virtual — no modifier needed). **Transitional Care Management:** 99495/99496 (follow-up can be virtual). **Remote Patient Monitoring:** 99453 (initial setup), 99454 (device supply), 99457/99458 (management services). **Telephone E/M:** 99441 (5-10 min), 99442 (11-20 min), 99443 (21-30 min) — audio-only. **Specialty Consultations:** Many specialist consultations are eligible — check the CMS Telehealth Services List updated quarterly. **Not Eligible for Telehealth:** Physical examinations requiring hands-on assessment, procedures, some surgical follow-ups requiring wound inspection. **Key Rule:** Always verify the CPT code is on the CMS-approved telehealth list and the payer's specific telehealth policy before scheduling virtual visits.

SLP codes: evaluations 92521-92524, treatment 92507, swallowing treatment 92526, clinical swallowing eval 92610, MBSS 92611, FEES 92612-92617, cognitive 97129/97130, AAC assessment 92607/92608. Primary treatment code is 92507.

SLP procedure codes: **Evaluations:** 92521 (fluency evaluation), 92522 (speech sound production), 92523 (speech sound + language comprehension/expression — most common), 92524 (voice and resonance). **Treatment:** 92507 (speech/language/communication treatment — the primary SLP treatment code), 92526 (treatment of swallowing dysfunction). **Swallowing Assessment:** 92610 (clinical swallowing evaluation), 92611 (motion fluoroscopic swallowing study — MBSS/videofluoroscopy), 92612-92617 (FEES — flexible endoscopic evaluation of swallowing). **Cognitive Intervention:** 97129 (first 15 min), 97130 (each additional 15 min) — for cognitive-linguistic therapy. **AAC Assessment:** 92607 (evaluation for AAC device, first hour), 92608 (each additional 30 min). **Voice Analysis:** 92520 (laryngeal function studies). **Shared Codes:** 97110 (therapeutic exercise), 97530 (therapeutic activities), 92508 (group treatment). **Key Rule:** 92507 and 97530 cannot both be billed on the same day unless they address clearly different goals with separate documentation.

Sports medicine codes: joint injections 20610/20605/20600, PRP 0232T (patient-pay only), knee arthroscopy 29880-29888, shoulder arthroscopy 29806-29827, concussion assessment 99483/96116. Modifier 25 for E/M with procedures.

Sports medicine procedure codes: **Joint Injections:** 20610 (major joint — shoulder, hip, knee), 20605 (intermediate — wrist, elbow), 20600 (small — fingers, toes). **PRP (Non-Covered):** 0232T (PRP injection) — category III code, not covered by most payers; patient-pay. **Ultrasound Guidance:** 76942 — separately billable with injection when documented. **Arthroscopy — Knee:** 29880 (meniscectomy), 29881 (meniscectomy with ACL repair), 29888 (ACL reconstruction). **Arthroscopy — Shoulder:** 29806 (capsulorrhaphy), 29807 (SLAP repair), 29827 (rotator cuff repair). **Concussion Codes:** 99483 (cognitive assessment), 96116 (neurobehavioral status exam — first hour), 96121 (each additional hour), 96132-96133 (neuropsychological testing). **Fracture Care:** Standard orthopedic fracture care codes by location and treatment approach. **E/M with Procedures:** Use modifier 25 for separately identifiable evaluation. **Key Rule:** PRP and stem cell injections should never be submitted to insurance — document as patient-pay with appropriate informed consent.

In-office endocrinology: thyroid FNA 10005/10006 (includes US guidance), thyroid ultrasound 76536, DEXA 77080/77081, CGM 95250/95251. FNA 10005 includes imaging guidance. DEXA every 2 years Medicare. CGM requires 72-hour written interpretation.

In-office endocrinology procedure codes: **Thyroid FNA:** 10005 (FNA with ultrasound guidance, first lesion), 10006 (each additional lesion). Replaces old 10022 code as of 2024. **Thyroid Ultrasound:** 76536 (ultrasound of thyroid, complete — includes both lobes, isthmus, and surrounding structures). **Bone Density (DEXA):** 77080 (DXA, axial skeleton — most common, hip and spine), 77081 (appendicular skeleton), 77085 (axial + vertebral fracture assessment). **CGM Professional:** 95250 (sensor placement, up to 72 hours), 95251 (interpretation and report, minimum 72 hours). **Thyroid Biopsy Pathology:** 88172 (cytopathology, FNA with immediate evaluation) — performed during FNA to assess adequacy. **Key Rules:** FNA with ultrasound guidance (10005) includes the imaging guidance — do not bill 76942 separately. DEXA frequency: Medicare covers every 2 years (23 months minimum), or sooner with qualifying clinical change. CGM 95251 requires written interpretation report documenting glycemic patterns and treatment modifications.

EGD codes: 43235 (diagnostic), 43239 (biopsy), 43247 (foreign body), 43248-43249 (dilation), 43255 (bleeding control), 43251 (polypectomy), 43266 (stent). Diagnostic EGD bundles into surgical codes. Modifier 59 for distinct site procedures.

EGD procedure codes: **Diagnostic:** 43235 (diagnostic EGD with or without collection of specimens by brushing or washing). **Biopsy:** 43239 (EGD with biopsy, single or multiple). **Foreign Body Removal:** 43247 (removal of foreign body). **Dilation:** 43248 (with dilation by wire-guided technique), 43249 (with balloon dilation — esophageal/gastric). **Hemorrhage Control:** 43255 (with control of bleeding by any method). **Polypectomy:** 43251 (with snare removal of tumor/polyp). **Stent Placement:** 43266 (with placement of endoscopic stent). **PEG Tube:** 43246 (with placement of percutaneous gastrostomy tube). **Bundling Rules:** Diagnostic EGD (43235) is included in all surgical EGD codes — never bill separately. Biopsy (43239) can be billed with other surgical codes when performed at different anatomic sites. **Modifier 59:** Required when multiple distinct EGD procedures are performed at clearly separate sites (e.g., esophageal dilation + gastric biopsy). **Documentation:** Specify each anatomic site, procedure performed, and findings at each location.

Cranial surgery: tumor craniotomy 61510-61520, hematoma 61312-61313, burr holes 61154-61156, stereotactic navigation 61781-61783 (add-on), VP shunt 62223, DBS 61860-61886. Co-surgeon modifier 62 for skull base approaches. 90-day global period.

Cranial neurosurgery codes: **Craniotomy for Tumor:** 61510 (supratentorial, except meningioma), 61512 (meningioma), 61518 (infratentorial), 61520 (cerebellopontine angle tumor). **Craniotomy for Hematoma:** 61312 (supratentorial epidural/subdural), 61313 (subdural, chronic). **Burr Holes:** 61156 (drainage of subdural hematoma), 61154 (drainage of epidural hematoma). **Stereotactic Procedures:** 61781-61783 (stereotactic navigation — add-on codes), 61790 (stereotactic radiosurgery — Gamma Knife/CyberKnife). **Ventriculostomy/Shunt:** 62223 (ventriculoperitoneal shunt creation), 62225 (shunt replacement), 62230 (valve/catheter replacement). **Deep Brain Stimulation:** 61860-61868 (electrode placement), 61885-61886 (neurostimulator generator placement). **Key Rules:** Co-surgeon modifier 62 applies when two surgeons of different specialties work together (e.g., neurosurgeon + ENT for skull base approaches). 90-day global period applies to all major cranial procedures. Separately bill stereotactic navigation (61781-61783) as add-on codes when used.

Code Mohs surgery by stage (17311-17314) based on site, plus separate closure/repair codes as appropriate.

Mohs surgery uses CPT codes 17311 (first stage, up to 5 tissue blocks, head/neck/hands/feet/genitalia), 17312 (each additional stage, same criteria), 17313 (first stage, trunk/extremities), and 17314 (each additional stage, same criteria). The surgeon also codes the wound repair/closure separately using appropriate repair codes (12001-13160 for simple/intermediate/complex repairs, 14000-14350 for adjacent tissue transfer, or 15100-15278 for grafts). Modifier -59 may be needed for multiple lesion sites. Pathology interpretation is included in the Mohs codes.

Code fractures by treatment type (closed/open) and anatomical site; initial casting is included in the fracture care code.

Fracture care coding depends on the treatment approach: (1) Closed treatment without manipulation — 2XXXX codes specific to anatomical site; (2) Closed treatment with manipulation — higher-valued codes for the same site; (3) Open treatment (ORIF) — surgical codes with 90-day global periods. Initial casting/splinting is included in the fracture care code. Subsequent cast changes use 29000-29799 series. Follow-up visits during the global period are included unless a separate problem is addressed (modifier -24). Multiple fractures are coded individually. X-ray interpretation (7XXXX codes) is billed separately with modifier -26 for the professional component.

Vascular access codes: AV fistula creation 36818-36821, AV graft 36825-36830, thrombectomy 36831/36870, angioplasty 36902/36905, catheter placement 36556-36558. Imaging guidance (76937) is separately billable with documentation.

Vascular access procedure codes: **AV Fistula:** 36818-36820 (creation by vessel type), 36821 (direct arteriovenous anastomosis). **AV Graft:** 36825-36830 (creation by vessel/type). **Declotting/Thrombectomy:** 36831 (open thrombectomy), 36870 (percutaneous thrombectomy). **Angioplasty:** 36902 (percutaneous transluminal angioplasty of AV access), 36905 (with stent). **Catheter Placement:** 36556-36558 (central venous catheter), 36580 (catheter replacement), 36589 (removal). **Monitoring:** 36901 (introduction of catheter for dialysis circuit angiography). **Important billing considerations:** Vascular access procedures may be performed by nephrologists, vascular surgeons, or interventional radiologists — correct provider credentialing and place-of-service coding are essential. Imaging guidance codes (76937 for ultrasound vascular access) are separately billable when documented.

Key audiology codes: 92557 (comprehensive audiometry), 92550 (tympanometry with reflexes), 92558/92587 (OAE), 92585 (ABR), 92540/92548 (vestibular). Audiologists bill under own NPI or incident-to. Medicare covers diagnostic but not hearing aid evaluations.

Audiometric testing codes in ENT: **Pure Tone Audiometry:** 92552 (air only), 92553 (air and bone). **Speech Audiometry:** 92555 (speech recognition threshold), 92556 (with speech recognition testing). **Comprehensive Audiometry:** 92557 (includes 92553 + 92556 — most commonly billed). **Tympanometry:** 92550 (includes 92567 tympanometry + 92568 acoustic reflex testing). **OAE Testing:** 92558 (otoacoustic emissions screening), 92587/92588 (diagnostic OAE). **ABR/BERA:** 92585 (auditory brainstem response). **Vestibular Testing:** 92540 (basic vestibular evaluation), 92548 (computerized posturography). **Billing rules:** Audiologists bill under their own NPI when credentialed, or incident-to the physician. Medicare requires the ordering physician to document medical necessity for all audiology services. Hearing aid evaluations (92590-92595) are not covered by Medicare.

Drug billing: Calculate units per J-code specification (e.g., J9271 pembrolizumab per 1mg = 200 units for 200mg dose). Report waste with JW modifier. Include NDC/lot numbers. Medicare reimburses at ASP+6% updated quarterly.

Oncology drug billing requires precise HCPCS coding: **Unit Calculation:** Each J-code specifies a billing unit (per 1mg, per 10mg, per 50mg). Example: Keytruda (pembrolizumab) J9271 = per 1mg, so a 200mg dose = 200 units. Opdivo (nivolumab) J9299 = per 1mg. Herceptin (trastuzumab) J9355 = per 10mg. **Waste Reporting:** If a single-use vial is partially used, report waste with JW modifier (e.g., 440mg vial used for 400mg dose = 40mg waste with JW modifier). **NDC Documentation:** Many payers require NDC (National Drug Code), lot number, and manufacturer on the claim. **ASP-Based Reimbursement:** Medicare reimburses at ASP+6% — payers update ASP quarterly, so reimbursement changes every January, April, July, October. **Biosimilar Billing:** Biosimilars have their own HCPCS codes and are reimbursed at the biosimilar ASP+6%, not the reference product ASP.

Bronchoscopy codes: 31622 (diagnostic), 31625/31628/31629 (biopsies), 31624 (BAL), 31636 (stent), 31652-31653 (EBUS). Diagnostic scope bundles into surgical codes. BAL billable separately when performed in different lobe from biopsy.

Bronchoscopy coding: **Diagnostic:** 31622 (diagnostic bronchoscopy with or without cell washing). **Biopsy:** 31625 (bronchial biopsy), 31628 (transbronchial lung biopsy), 31629 (needle aspiration biopsy). **BAL:** 31624 (bronchoalveolar lavage). **Therapeutic:** 31634 (balloon occlusion), 31636 (stent placement), 31641 (tumor destruction). **Navigation:** 31627 (computer-assisted navigation — add-on code). **EBUS:** 31652 (endobronchial ultrasound with sampling, first node), 31653 (each additional node). **Key Bundling Rules:** Diagnostic bronchoscopy (31622) is included in all surgical bronchoscopy codes — never bill separately. BAL (31624) can be billed with biopsy codes when performed in a different lobe. For bilateral procedures, use modifier 50. Each additional biopsy site beyond the first uses add-on codes where available. **Documentation:** Must specify: lobe/segment examined, findings, procedure performed at each site, specimens obtained.

Intravitreal injection: 67028 + J-code for drug. Laser: 67210 (focal), 67228 (PRP). Vitrectomy: 67036. OCT: 92134 (retinal), 92133 (optic nerve). E/M with injection requires modifier 25 and separately documented evaluation.

Retinal procedure codes: **Intravitreal Injection:** 67028 — used for anti-VEGF drugs (Eylea/aflibercept, Lucentis/ranibizumab, Avastin/bevacizumab). Bill drug separately with J-code (J0178 for aflibercept, J2778 for ranibizumab, J9035 for bevacizumab). **Bilateral:** Use modifier 50 or RT/LT for bilateral injections on the same day. **Laser Photocoagulation:** 67210 (focal), 67220 (choroidal lesion), 67228 (extensive retinal treatment). **PRP (Panretinal):** 67228 — often requires multiple sessions; each session is separately billable. **Vitrectomy:** 67036 (mechanized vitrectomy, pars plana approach). **Fluorescein Angiography:** 92235 — separately billable with medical necessity documentation. **OCT:** 92134 (retinal scan), 92133 (optic nerve scan) — one per eye per visit, requires medical necessity for each test. **Critical Rule:** E/M can be billed with injection only if a separately identifiable evaluation is performed and documented — append modifier 25.

Facet injection codes: 64490-64492 (cervical/thoracic by level), 64493-64495 (lumbar/sacral). RFA: 64633-64636. Fluoroscopy included. Bilateral use modifier 50. Payers require 2 diagnostic blocks with 80%+ relief before RFA approval.

Facet and medial branch block coding: **Facet Joint Injection:** 64490 (cervical/thoracic, first level), 64491 (second level), 64492 (third and beyond). 64493 (lumbar/sacral, first level), 64494 (second level), 64495 (third and beyond). **Medial Branch Block:** Use same codes as facet joint injections — 64490-64495 depending on region and level. **Radiofrequency Ablation (RFA):** 64633 (cervical/thoracic, first two facet joints), 64634 (each additional joint). 64635 (lumbar/sacral, first two joints), 64636 (each additional joint). **Imaging Guidance:** Fluoroscopic guidance is included in facet/MBB codes — do not bill 77003 separately. **Bilateral:** Use modifier 50 for bilateral procedures at the same level. **Medical Necessity:** Most payers require two diagnostic medial branch blocks (at least 80% pain relief documented) before approving RFA. **Documentation:** Must specify each level treated, laterality, needle placement under fluoroscopy, and response to diagnostic blocks.

Immunotherapy: 95165 (preparation per dose — bill all doses at mixing), 95115 (single injection per visit), 95117 (2+ injections per visit). Preparation and injection are billed separately. E/M with injection only with modifier 25 for separately identifiable service.

Immunotherapy billing has two components: **Preparation/Mixing:** 95165 (professional services for allergen immunotherapy, single or multiple antigens per dose) — billed per dose prepared. A 1-year supply of weekly injections = 52 doses. Report total doses prepared at time of mixing. **Injection Administration:** 95115 (single injection), 95117 (two or more injections — use when patient receives injections from multiple vials in same visit). **Sublingual Immunotherapy (SLIT):** No specific CPT code — typically billed as unlisted (95199) or not separately billable depending on payer. **Key Rules:** 95165 covers the antigen preparation — billed when the extract is mixed, not when injected. 95115/95117 covers the injection administration — billed at each visit. E/M is not separately billable with allergy injection unless a significant, separately identifiable service is performed (modifier 25). **Documentation:** Each injection log must document vial number, dose, injection site, and any reaction.

GYN procedure codes: Hysterectomy 58150/58260/58571 by approach. Colposcopy 57452-57460. D&C 58120. Hysteroscopy 58558/58563. IUD 58300/58301. Use modifier 22 for increased complexity and document clinical justification.

Key GYN procedure codes: **Hysterectomy:** 58150 (total abdominal, TAH), 58260 (vaginal, VH), 58571 (total laparoscopic, TLH), 58572 (TLH with tubes/ovaries). **Laparoscopy:** 58660 (lysis of adhesions), 58661 (excision of lesions/endometriosis), 58662 (excision with fulguration). **Colposcopy:** 57452 (with biopsy), 57454 (with biopsy and endocervical curettage), 57460 (with LEEP). **D&C:** 58120 (diagnostic or therapeutic dilation and curettage). **Hysteroscopy:** 58558 (with biopsy/polypectomy), 58563 (with ablation). **Endometrial Ablation:** 58353 (thermal). **IUD:** 58300 (insertion), 58301 (removal). **Bilateral Salpingectomy:** 58700 (open), 58661 (laparoscopic — code based on approach and additional procedures). **Modifiers:** Use modifier 22 for increased complexity (extensive adhesions, enlarged uterus >250g). Use modifier 50 for bilateral procedures when applicable.

Joint replacement codes: TKR 27447, partial knee 27446, THR 27130, hemiarthroplasty 27125. Revision: 27486-27487 (knee), 27134-27137 (hip). Bilateral modifier 50. 90-day global includes post-op care. PT, complications, and unrelated visits are separate.

Joint replacement codes: **Total Knee Replacement (TKR):** 27447 (total knee arthroplasty). **Partial Knee Replacement:** 27446 (unicompartmental). **Revision TKR:** 27486 (one component), 27487 (all components). **Total Hip Replacement (THR):** 27130 (total hip arthroplasty). **Partial Hip (Hemiarthroplasty):** 27125. **Revision THR:** 27134 (one component), 27137 (acetabular and femoral). **Hip Resurfacing:** 27299 (unlisted). **Bilateral:** Use modifier 50 — reimbursement typically 150% of unilateral rate. **Implant Billing:** Bill prosthetic components separately using appropriate HCPCS codes. **Bundled Services:** Pre-operative H&P (day before/day of), surgery, all post-operative care for 90 days, routine x-rays during global period. **Not Bundled:** Physical therapy (separate provider), complications requiring return to OR (modifier 78), unrelated E/M visits (modifier 24).

Key PT codes: 97110 (therapeutic exercise), 97140 (manual therapy), 97112 (neuromuscular re-ed), 97530 (therapeutic activities), 97116 (gait training). Evaluations: 97161-97163. Modalities: 97010, 97014, 97035.

The most frequently billed PT codes include: **Therapeutic Exercises (97110):** Exercises to develop strength, endurance, flexibility — the most commonly billed PT code. **Manual Therapy (97140):** Skilled hands-on techniques including mobilization and manipulation. **Neuromuscular Re-education (97112):** Movement, balance, coordination, kinesthetic sense, posture training. **Therapeutic Activities (97530):** Dynamic activities to improve functional performance. **Gait Training (97116):** Walking and stair climbing training. **Evaluations:** 97161 (low complexity), 97162 (moderate), 97163 (high complexity). **Re-evaluations:** 97164. **Modalities (supervised):** Hot packs (97010), electrical stimulation (97014). **Modalities (constant attendance):** Ultrasound (97035), iontophoresis (97033). **Untimed codes** like evaluations are billed per encounter, while **timed codes** like 97110 use the 8-minute rule for unit calculation.

Main plan types include HMO, PPO, EPO, POS, HDHP, Medicare, Medicaid, Workers' Comp, and TRICARE.

Major health insurance plan types include: (1) HMO (Health Maintenance Organization) — requires primary care physician referrals, limited to in-network providers; (2) PPO (Preferred Provider Organization) — more provider flexibility, higher out-of-network costs; (3) EPO (Exclusive Provider Organization) — no out-of-network coverage except emergencies; (4) POS (Point of Service) — hybrid of HMO and PPO; (5) HDHP (High Deductible Health Plan) — lower premiums, higher deductibles, often paired with HSA; (6) Medicare (Original A/B, Advantage Part C, Part D); (7) Medicaid — state-administered; (8) Workers' Compensation; (9) TRICARE for military.

Electronic claims typically take 14-30 days; paper claims may take 45-60 days depending on the payer.

Most electronic claims are processed within 14-30 days, depending on the payer. Medicare requires payment within 30 days for electronic claims and 45 days for paper claims. Commercial payers vary but typically process clean claims within 15-45 days. Paper claims take significantly longer, often 45-60 days. Claims requiring manual review, additional documentation, or prior authorization verification may take longer. State prompt-pay laws may also set maximum timeframes for claim processing.

In-network providers have contracted rates with lower patient costs; out-of-network providers charge full fees with higher patient responsibility.

In-network providers have contracted rates with insurance companies, accept agreed-upon reimbursement, and patients typically pay lower cost-sharing. Out-of-network providers have no contract, can charge their full fee schedule, and patients face higher deductibles, coinsurance, and potential balance billing. Key differences: (1) In-network claims are processed at contracted rates; (2) Out-of-network claims may be processed at usual, customary, and reasonable (UCR) rates; (3) Balance billing is prohibited for in-network services but may be allowed out-of-network (subject to state laws and the No Surprises Act); (4) Prior authorization requirements may differ.

Dental plans typically have $1,000-$2,500 annual maximums with coverage tiers: 100% preventive, 80% basic, 50% major.

Most dental insurance plans have an annual maximum benefit, typically ranging from $1,000-$2,500 per person per year. Once the maximum is reached, the patient is responsible for 100% of remaining costs. Plans typically cover preventive services at 100%, basic services (fillings, extractions) at 80%, and major services (crowns, bridges) at 50%. Many plans also have a deductible ($25-$100) that must be met before benefits apply to basic and major services. Orthodontic benefits often have a separate lifetime maximum.

Mohs surgery, biologic medications, phototherapy, and certain injectable treatments often require prior auth.

Common dermatology procedures requiring prior authorization include: Mohs micrographic surgery (especially for non-facial lesions), biologic medications for psoriasis (adalimumab, secukinumab, etc.), phototherapy (UVB, PUVA), cosmetic procedures when claimed as medically necessary, allergy testing, advanced wound care treatments, and certain injectable medications. Requirements vary significantly by payer, so it's essential to verify authorization requirements for each patient's specific plan before performing services.

Common orthopedic pre-auths include advanced imaging, joint replacements, spinal surgery, and injections.

Common orthopedic procedures requiring prior authorization include: (1) MRI, CT scans, and advanced imaging; (2) Joint replacement surgeries (hip, knee, shoulder); (3) Arthroscopic procedures; (4) Spinal surgeries (fusion, decompression, disc replacement); (5) DME such as braces, orthotics, and wheelchairs; (6) Physical therapy beyond initial visits; (7) Injections (joint, epidural steroid, viscosupplementation); (8) Outpatient vs. inpatient status for surgical procedures. Authorization requirements vary by payer and plan, so always verify before scheduling procedures.

Medicaid pediatric billing involves lower rates, EPSDT preventive services, VFC vaccine programs, and state-specific rules.

Medicaid pediatric billing involves several unique considerations: (1) Reimbursement rates are generally lower than Medicare and commercial rates; (2) EPSDT (Early and Periodic Screening, Diagnostic, and Treatment) provides comprehensive preventive services for children under 21; (3) Vaccines may be covered under the Vaccines for Children (VFC) program, with only administration fees billable; (4) State-specific Medicaid managed care plans have varying rules; (5) Timely filing limits are typically 90-365 days depending on the state; (6) Some states require specific modifiers or procedure codes; (7) Prior authorization requirements vary by state plan.

Bill cardiac devices by coding both the procedure (33206-33264) and the device separately; verify payer requirements.

Cardiac device implantation billing requires coding for both the procedure and the device: (1) Pacemaker insertion — 33206-33208 based on lead placement; (2) ICD implantation — 33249; (3) CRT-D — 33224-33225 for lead placement plus 33249 for generator; (4) Device replacement — 33227-33229 for pacemaker, 33262-33264 for ICD; (5) Lead revision/extraction — 33233-33244. The device itself is coded separately using HCPCS C-codes in the outpatient setting. Hospital facility fees and professional fees are billed separately. Verify payer-specific requirements for device registration and prior authorization.

Mental health parity law requires equal insurance coverage for mental health and medical/surgical conditions.

The Mental Health Parity and Addiction Equity Act (MHPAEA) requires that insurance plans offering mental health benefits must provide coverage that is no more restrictive than coverage for medical/surgical conditions. This applies to financial requirements (deductibles, copays), treatment limitations (visit limits, prior authorization), and non-quantitative treatment limitations (fail-first requirements, network adequacy). Billing practices should track and challenge any payer denials that appear to violate parity requirements.

Value-based care ties reimbursement to quality metrics, affecting Medicare payments through MIPS/MACRA and commercial payer programs.

Value-based reimbursement shifts payment from volume to quality outcomes. Family medicine practices are affected through: (1) MIPS/MACRA reporting requirements that adjust Medicare payments +/- 9%; (2) Accountable Care Organizations (ACOs) that share savings/losses; (3) Pay-for-performance programs from commercial payers; (4) Quality measures including preventive care rates, chronic disease management, and patient satisfaction. Practices should invest in care management infrastructure, quality reporting systems, and patient engagement tools to maximize value-based reimbursement.

Common urology prior auths: robotic surgery, prosthesis implantation, neuromodulation devices, advanced imaging, urodynamics, injectable medications, and DME. Submit 2-3 weeks early with clinical indications and failed conservative treatment documentation.

Prior authorization requirements in urology vary by payer but commonly include: **Surgical Procedures:** Robotic-assisted prostatectomy, nephrectomy (partial or radical), penile prosthesis implantation, artificial urinary sphincter, sacral neuromodulation (InterStim). **Diagnostic:** Advanced imaging (CT urogram, MRI prostate), urodynamic studies, cystoscopy in certain payer plans. **Medications:** Injectable medications (BCG for bladder cancer, testosterone therapy, GnRH agonists for prostate cancer). **DME:** Intermittent catheters, external collection devices, penile clamps. **Documentation requirements:** Clinical indication, failed conservative treatment, diagnostic test results, pathology reports for cancer cases. **Timeline:** Submit 2-3 weeks before scheduled procedures. Emergency cystoscopies for hematuria or obstruction typically have retrospective auth pathways.

Biologic prior auth requires: 1-2 failed conventional DMARDs, disease activity scores (DAS28/CDAI), lab results, imaging, and functional assessments. Renewal every 6-12 months with updated scores. Missing deadlines causes treatment interruption.

Biologic prior authorization in rheumatology is extensive: **Step Therapy Requirements:** Most payers require documented failure of 1-2 conventional DMARDs (methotrexate, hydroxychloroquine, sulfasalazine, leflunomide) before approving biologics. **Documentation Needed:** Disease activity scores (DAS28 or CDAI), failed medication history with dates, doses, and reasons for discontinuation, lab results (RF, anti-CCP, ESR, CRP), imaging showing disease progression, and functional status assessment. **Common Biologics Requiring Auth:** TNF inhibitors (Humira/adalimumab, Enbrel/etanofexceptcept, Remicade/infliximab), IL-6 inhibitors (Actemra/tocilizumab), JAK inhibitors (Xeljanz/tofacitinib, Rinvoq/upadacitinib), T-cell costimulation inhibitors (Orencia/abatacept), B-cell depleting agents (Rituxan/rituximab). **Renewal:** Most biologics require re-authorization every 6-12 months with updated disease activity scores showing treatment response. Missing renewal deadlines means treatment interruption.

The 2025 Medicare therapy cap is $2,410 for PT/SLP combined. Above this amount, append KX modifier to certify medical necessity. At $3,000, targeted medical review applies. Documentation must show objective progress and skilled care need.

The Medicare therapy cap for 2025 is $2,410 for physical therapy and speech-language pathology combined (separate $2,410 cap for occupational therapy). Once a patient exceeds this threshold, therapists must append the KX modifier to all subsequent claims, certifying that the services are medically necessary and that documentation in the medical record supports continued treatment. At $3,000 in expenditures, claims undergo targeted medical review. Documentation must include: (1) objective measurable progress, (2) skilled care justification, (3) treatment plan updates, and (4) functional outcome measures. Without the KX modifier, claims above the cap are automatically denied. If a patient exceeds the cap but services are not medically necessary, billing with KX is considered fraud. The therapy cap applies per beneficiary across all providers — so if a patient sees two PT practices, their combined charges count toward the single cap.

Cancer treatment prior auths: chemotherapy regimens with NCCN guideline documentation, immunotherapy with companion diagnostics, radiation therapy, molecular testing, PET/CT scans. Submit 5-10 days early. Urgent cases qualify for expedited review.

Oncology prior authorization requirements are extensive: **Chemotherapy Regimens:** Most commercial payers require prior auth for all chemotherapy protocols, with documentation of cancer type, stage, biomarker results, and NCCN guideline-concordant treatment selection. **Immunotherapy:** PD-1/PD-L1 inhibitors, CAR-T cell therapy, and other biologics require prior auth with companion diagnostic results. **Radiation Therapy:** Treatment planning and delivery often require prior auth with tumor board documentation and treatment rationale. **Molecular/Genetic Testing:** Comprehensive genomic profiling (Foundation Medicine, Tempus, Guardant) requires prior auth with documentation of how results will impact treatment decisions. **PET/CT Scans:** Typically require prior auth for staging and restaging with specific ICD-10 codes. **Clinical Trial Services:** Qualifying services are covered by insurance, but non-qualifying trial-specific services are sponsor responsibility — requires careful separation. **Timeline:** Submit 5-10 business days before treatment start; urgent/emergent cases may qualify for expedited review.

Common denial reasons include coding errors, missing authorization, invalid patient info, and timely filing issues.

The most common claim denial reasons include: (1) Missing or invalid patient information, (2) Incorrect or mismatched CPT/ICD-10 codes, (3) Lack of prior authorization, (4) Duplicate claim submission, (5) Timely filing limit exceeded, (6) Non-covered services, (7) Coordination of benefits issues, (8) Incorrect provider information or NPI, (9) Medical necessity not established, and (10) Bundling/unbundling errors. Most denials are preventable with proper front-end processes and claim scrubbing.

Coding audits review records for accuracy and compliance; perform quarterly internal and annual external audits.

A coding audit is a systematic review of medical records and claims to evaluate coding accuracy, documentation adequacy, and compliance with regulations. Types include: (1) Prospective audits — review before claim submission; (2) Retrospective audits — review after claim submission; (3) Targeted audits — focus on specific codes or providers; (4) Random sample audits — statistically representative review. Best practices recommend: quarterly internal audits of at least 10-20 charts per provider, annual external audits, and targeted audits when trends suggest potential issues. Audit accuracy targets should be 95% or higher.

Billing fraud consequences include fines up to $11,000 per claim, imprisonment, program exclusion, and license loss.

Consequences of billing fraud include: (1) Civil penalties under the False Claims Act — up to $11,000 per false claim plus treble damages; (2) Criminal penalties — fines up to $250,000 and imprisonment up to 10 years; (3) Exclusion from Medicare, Medicaid, and other federal healthcare programs; (4) Loss of medical licensure; (5) Corporate Integrity Agreements (CIAs) requiring ongoing compliance monitoring; (6) Whistleblower lawsuits under qui tam provisions; (7) Reputational damage. Even unintentional billing errors can trigger audits and recoupment if they form a pattern.

The Stark Law prohibits physician self-referrals for designated health services to entities with financial relationships, with limited exceptions.

The Physician Self-Referral Law (Stark Law) prohibits physicians from referring Medicare/Medicaid patients for designated health services (DHS) to entities with which they or their immediate family members have a financial relationship, unless an exception applies. DHS includes clinical laboratory services, physical therapy, radiology, DME, and more. Violations result in: denial of payment, refund obligations, civil monetary penalties up to $15,000 per service, treble damages, and program exclusion. Common exceptions include the in-office ancillary services exception, fair market value compensation, and bona fide employment arrangements.

Cardiology E/M documentation must support MDM level through problem complexity, data review, and risk assessment.

Cardiology E/M documentation must support the level of medical decision-making (MDM) billed. For 2024+ guidelines, documentation should clearly reflect: (1) Number and complexity of problems addressed, (2) Amount and complexity of data reviewed (including review of prior cardiac studies, external records, and test ordering), (3) Risk of complications and management decisions. Cardiology-specific documentation should include cardiac history, current medications, relevant test results, assessment of cardiac conditions, and the treatment plan.

Bill developmental screening with 96110 using validated tools; AAP recommends screenings at 9, 18, and 30 months.

Developmental screening billing requirements include: (1) Use CPT 96110 for developmental screening with a standardized instrument (e.g., ASQ-3, PEDS, M-CHAT); (2) The screening tool must be a validated, standardized instrument with published reliability data; (3) Document the specific screening tool used, the results, and any follow-up actions; (4) AAP recommends developmental screening at 9, 18, and 30 months; (5) Autism-specific screening is recommended at 18 and 24 months using M-CHAT-R/F; (6) Bill 96127 for emotional/behavioral assessment (e.g., PHQ-A for adolescent depression); (7) Modifier -25 may be needed if billed with a preventive visit; (8) Most payers cover age-appropriate screenings as preventive services.

Medical procedures require documented medical necessity; cosmetic procedures are patient-pay. Clear documentation distinguishes the two.

Distinguishing cosmetic from medical procedures is critical for billing compliance: (1) Medical procedures require documentation of medical necessity including diagnosis, symptoms, functional impairment, and failed conservative treatments; (2) Cosmetic procedures are not covered by insurance and must be billed directly to the patient; (3) Some procedures can be either medical or cosmetic (e.g., blepharoplasty for visual field obstruction vs. aesthetics); (4) Documentation must clearly support the medical indication with clinical findings, photographs, and test results where applicable; (5) Mixing cosmetic and medical billing in the same encounter requires careful separation of charges.

Mental health notes must include session times, therapy type, interventions, patient response, and treatment plan updates.

Mental health documentation must include: (1) Patient identifying information and diagnosis, (2) Start and stop time of the session, (3) Type of therapy provided, (4) Issues discussed and interventions used, (5) Patient's response to treatment, (6) Treatment plan updates, (7) Risk assessment when applicable, and (8) Medical necessity for continued treatment. For psychiatric E/M services billed with add-on psychotherapy codes, both the E/M and psychotherapy components must be separately documented.

Urology compliance risks include robotic surgery coding errors, prostate biopsy over-billing, modifier 25 abuse with cystoscopies, implant billing markup issues, Stark Law self-referral concerns, and laterality documentation gaps.

Key urology compliance risks: **Robotic Surgery Coding:** Billing robotic-assisted procedures with incorrect codes or double-billing the robotic component. **Prostate Biopsy Over-Billing:** Billing extended template biopsies (more than 12 cores) without documentation justifying the additional samples. **Modifier 25 Abuse:** Routinely appending modifier 25 to E/M visits with same-day cystoscopies without documenting a separately identifiable E/M service. **Implant Billing:** Billing for implant devices at marked-up costs or unbundling device placement from surgical procedure codes. **Stark Law/Self-Referral:** Urologists referring patients to their own ancillary services (imaging, lab, pathology) must comply with in-office ancillary services exception requirements. **Documentation Gaps:** Missing laterality documentation for bilateral procedures, incomplete operative notes for complex reconstructive procedures.

PT documentation requires: initial evaluation with baselines, plan of care certified by physician every 90 days, daily notes with start/stop times for timed codes, progress notes every 10 visits or 30 days, and discharge summary.

Medicare and most payers require comprehensive PT documentation: **Initial Evaluation:** Must include history, systems review, tests and measures with objective baselines, assessment with clinical impression, and a plan of care with frequency, duration, and goals. **Plan of Care:** Must be certified (signed) by the referring physician within 30 days of treatment start, recertified every 90 days. **Daily Treatment Notes:** Must document each service provided with start/stop times for timed codes, skilled interventions performed, patient response, and progress toward goals. **Progress Notes:** Required at least every 10th visit or every 30 days (whichever comes first), documenting objective progress toward goals. **Discharge Summary:** Required at episode end. **Common audit triggers:** Missing physician signatures on plans of care, no objective progress documented, treating beyond maximum benefit, and billing timed codes without documented start/stop times.

Ophthalmology compliance risks: diagnostic test over-utilization, complex vs routine cataract upcoding, refraction ABN compliance, premium IOL billing separation, visual field frequency, and routine modifier 25 abuse with injections.

Ophthalmology compliance risks: (1) Diagnostic testing over-utilization — performing OCT, visual fields, fundus photos, and pachymetry on every visit without diagnosis-specific clinical justification, (2) Cataract surgery upcoding — billing complex cataract (66982) instead of routine (66984) without documenting qualifying complexity factors, (3) Refraction coverage — billing refraction (92015) to Medicare without ABN documentation and patient financial responsibility disclosure, (4) Premium IOL billing — failing to properly separate the patient-pay premium IOL upgrade cost from the insurance-covered standard IOL, creating potential double-billing, (5) Visual field testing frequency — performing and billing visual fields more frequently than medically necessary without documented disease progression, (6) Modifier 25 with intravitreal injections — routinely billing E/M with every injection visit without documenting a separately identifiable evaluation service.

Rheumatology compliance risks: drug waste reporting with JW modifier, buy-and-bill inventory documentation, E/M upcoding without MDM documentation, joint injection code accuracy, biologic therapy ongoing medical necessity, and infusion supervision requirements.

Rheumatology compliance risks: (1) Drug waste reporting — failure to report waste from single-use vials using JW modifier can trigger compliance concerns; similarly, using multi-dose vial contents for multiple patients must follow USP 797 standards, (2) Buy-and-bill drug documentation — practices must maintain accurate drug inventory records, NDC documentation, and lot numbers for all administered biologics, (3) E/M upcoding — routinely billing 99215 without documentation supporting the highest level of medical decision-making complexity, (4) Joint injection overcoding — billing major joint injection (20610) for small joint sites, or billing E/M with modifier 25 when the evaluation is not separately identifiable, (5) Biologic medical necessity — continuing biologic therapy without documented disease activity reassessment risks medical necessity denials and compliance scrutiny, and (6) Infusion supervision — inadequate physician supervision during biologic infusions creates liability and billing compliance issues.

Nephrology compliance risks: MCP visit count documentation integrity (OIG target), ESRD lab bundle violations, anti-kickback arrangements with dialysis facilities, telehealth-as-face-to-face billing, MCP/E/M overlap, and unsupported vascular access procedures.

Nephrology compliance risks: (1) MCP visit count fraud — documenting face-to-face visits that did not occur to qualify for higher MCP tier (90960 vs 90962) is a top OIG enforcement target, (2) ESRD lab bundling violations — billing separately for tests included in the ESRD PPS bundle (CBC, CMP, phosphorus, PTH monthly, iron studies, hepatitis B testing), (3) Kickback risks — arrangements with dialysis facilities, vascular access centers, or home health agencies that involve referral-based compensation violate the Anti-Kickback Statute, (4) Telehealth MCP — billing telemedicine visits as face-to-face MCP encounters when the visit does not meet face-to-face requirements, (5) Overlap billing — billing both MCP and separate E/M codes for the same diagnosis during the same month, and (6) Vascular access procedure documentation — performing and billing frequent vascular access procedures without documenting clinical indications for each intervention.

Lab compliance risks: medical necessity validation failures, panel unbundling fraud, reflexive testing without orders, kickback arrangements with referring physicians, Stark Law self-referral issues, ABN non-compliance, and specimen integrity standards.

Lab compliance risks: (1) Medical necessity validation — ordering tests without qualifying diagnoses is the #1 lab compliance issue; implement automated diagnosis-to-test edits before performing tests, (2) Panel unbundling — breaking apart complete panels into individual components to increase reimbursement constitutes fraud, (3) Reflexive testing — automatically performing additional tests without a physician order or standing order protocol violates medical necessity rules, (4) Kickback arrangements — providing free specimen collection supplies, couriers, or phlebotomy services to referring physicians in exchange for referrals violates the Anti-Kickback Statute, (5) Self-referral (Stark Law) — physician ownership in clinical labs must meet specific exceptions, (6) ABN compliance — performing non-covered tests without ABNs and then billing patients creates financial liability for the lab, and (7) Specimen integrity — billing for results from specimens that do not meet collection or handling standards compromises both quality and compliance.

ENT compliance risks: septoplasty/rhinoplasty distinction, endoscopy upcoding, allergy testing over-utilization, hearing aid dispensing conflicts, in-office CT self-referral, and routine modifier 25 abuse with endoscopy.

ENT compliance risks: (1) Septoplasty vs rhinoplasty — billing septoplasty (30520) for what is primarily a cosmetic rhinoplasty is a top fraud allegation in ENT; documentation must clearly demonstrate functional nasal obstruction, (2) Endoscopy upcoding — billing surgical nasal endoscopy codes when only a diagnostic examination was performed, (3) Allergy testing over-utilization — performing excessive skin tests (>80 per session) without clinical justification, (4) Hearing aid dispensing conflicts — practices that both diagnose hearing loss and sell hearing aids face self-referral scrutiny, (5) CT scan self-referral — in-office CT scans must meet Stark Law in-office ancillary services exception, (6) Modifier abuse — routinely billing modifier 25 with every endoscopy without documenting a separately identifiable E/M service.

Pain management compliance risks: injection frequency violations, UDS testing over-utilization (OIG target), missing fluoroscopy image documentation, inadequate medical necessity documentation, opioid prescribing documentation, and RFA without prior diagnostic blocks.

Pain management compliance risks: (1) Injection frequency — exceeding evidence-based injection frequency limits (3 epidurals per region per year) triggers audit scrutiny, (2) Urine drug testing — performing quantitative confirmatory testing (80320-80377) on every visit without clinical indication beyond presumptive screening is a top OIG target, (3) Documentation of imaging guidance — billing fluoroscopic guidance without saving and documenting spot images in the medical record, (4) Medical necessity for interventional procedures — performing injections without documented conservative treatment failure and functional improvement goals, (5) Pill mill indicators — high-volume opioid prescribing without adequate documentation of pain assessment, functional status, and risk stratification violates DEA and state medical board requirements, (6) RFA without diagnostic blocks — performing radiofrequency ablation without two prior diagnostic medial branch blocks showing 80%+ pain relief violates medical necessity criteria.

Medical billing services typically cost 4-10% of collections, $4-10 per claim, or a flat monthly fee.

Medical billing services are typically priced using one of three models: (1) Percentage of collections, ranging from 4-10% of collected revenue depending on practice size and specialty; (2) Per-claim fee, typically $4-$10 per claim; (3) Flat monthly fee, ranging from $1,000-$5,000+ based on volume. Factors affecting cost include specialty complexity, claim volume, number of providers, payer mix, and additional services like credentialing or prior authorization management.

Key billing KPIs include clean claim rate (95%+), DAR (under 35), denial rate (under 5%), and collection rate (95%+).

Essential medical billing KPIs include: (1) Clean claim rate — target 95%+; (2) Days in accounts receivable (DAR) — target under 35 days; (3) First pass resolution rate — target 90%+; (4) Denial rate — target under 5%; (5) Collection rate — target 95%+ of allowed amounts; (6) Net collection rate — total payments divided by allowed amounts; (7) Cost to collect — percentage of revenue spent on billing operations; (8) Claim rejection rate — target under 4%; (9) Patient collection rate; (10) Accounts receivable over 120 days — target under 12% of total A/R.

GI billing complexity: endoscopic procedure hierarchy/bundling, screening-to-diagnostic colonoscopy conversion, multiple polypectomy technique coding, anesthesia coordination, pathology correlation, and specialized testing codes.

GI billing complexity includes: (1) Endoscopic procedure hierarchy — upper endoscopy (EGD) and colonoscopy codes have strict bundling rules where the most comprehensive procedure code includes lesser procedures performed during the same session, (2) Screening vs diagnostic colonoscopy — the distinction affects copay, coinsurance, and coding: screening colonoscopy (G0121/G0105) converts to diagnostic (45380-45390) if a polyp is found and removed, creating patient billing confusion, (3) Multiple procedure coding — removing polyps at different colonic locations using different techniques in the same session requires careful code selection and modifier application, (4) Anesthesia billing interaction — many GI practices use propofol sedation (administered by CRNA or anesthesiologist) which is separately billable but must be coordinated with the endoscopist's charges, (5) Path lab coordination — every biopsy specimen generates a separate pathology charge that must correlate with the endoscopy procedure code, and (6) Capsule endoscopy and motility testing have specialized coding.

Podiatry billing uniqueness: Medicare routine foot care limitations with systemic condition qualifiers (Q7-Q9 modifiers), nail care coding specifics, bunionectomy approach-based coding, DME orthotic/shoe coverage criteria, and diabetic wound care coding.

Podiatry billing uniqueness: (1) Medicare coverage limitations — Medicare covers podiatric services only for treatment of disease or injury of the foot, with specific exclusions for routine foot care (cutting nails, treating corns/calluses) unless the patient has a qualifying systemic condition (diabetes, peripheral vascular disease), (2) Routine foot care modifiers — modifier Q7 (one qualifying condition), Q8 (two conditions), Q9 (three or more conditions) required for routine foot care to be covered, (3) Nail care coding — 11721 (debridement of nails, 6 or more) vs 11720 (1-5 nails), with specific documentation of nail condition and medical necessity, (4) Surgical foot procedures — bunionectomy coding varies by procedure type (28292-28299) with different approaches and fixation methods, (5) DME prescriptions — custom orthotics (L3000 series) and therapeutic shoes for diabetic patients (A5500-A5513) have specific coverage criteria, and (6) Wound care overlap — diabetic foot wound management shares codes with wound care specialty billing.

Urgent care billing uniqueness: high-volume encounter coding, E/M level accuracy across acuity range, procedure-plus-E/M modifier 25 management, after-hours billing, occupational medicine fee schedules, and self-pay collection challenges.

Urgent care billing uniqueness: (1) High-volume, short-encounter model — 40-80 patients per day per provider with average 15-minute encounters requires efficient coding and documentation, (2) E/M level selection — most urgent care visits fall in the 99202-99205 (new) or 99212-99215 (established) range, with the challenge of accurately capturing acuity without upcoding or downcoding, (3) Procedure-heavy visits — splinting, wound repair, I&D, foreign body removal, and point-of-care testing are common and require procedure-plus-E/M billing with modifier 25, (4) After-hours and weekend billing — codes 99051 (during office hours on days when office is normally closed) and modifier CT (complexity adjustment) may apply but coverage varies by payer, (5) Occupational medicine — workers comp visits, DOT physicals, drug screens, and employer-mandated services have different fee schedules and billing requirements, and (6) Walk-in patient demographics — higher uninsured/self-pay population requires transparent pricing and collection at time of service.

Chiropractic billing uniqueness: Medicare covers only spinal subluxation manipulation, requires AT modifier for active treatment, needs PART criteria documentation, limits ancillary service coverage, caps annual visits, and requires ABNs for maintenance care.

Chiropractic billing is unique due to: (1) Medicare coverage limitations — Medicare covers chiropractic manipulation (98940-98942) only for subluxation of the spine, excluding maintenance care, extremity adjustments, and most ancillary services, (2) AT modifier requirement — Medicare requires modifier AT (active treatment) on every CMT claim to certify the service is corrective rather than maintenance, (3) Subluxation documentation — Medicare requires either an x-ray demonstrating subluxation or a physical exam documenting at least 2 of 4 PART criteria (Pain/tenderness, Asymmetry/misalignment, Range of motion abnormality, Tissue/tone changes), (4) Limited ancillary service coverage — many payers do not cover adjunctive therapies (electrical stimulation, ultrasound, traction) when performed with manipulation, (5) Visit frequency limits — most payers cap annual chiropractic visits (12-30 per year), and (6) ABN requirements — Medicare requires ABN for maintenance care and non-covered services.

Anesthesia billing uses: base units + time units + modifying units × conversion factor. Physical status modifiers (P1-P6) add units. Medical direction (QK/QY for 1-4 CRNAs) vs supervision (AD for 5+). Time calculated from anesthesia start to end at 15 min/unit.

Anesthesia billing uses a unique formula-based system: (1) Base units + time units + modifying units = total units × conversion factor = payment. Base units are assigned by CPT code (00100-01999) reflecting procedure complexity. Time units are calculated from anesthesia start to end (1 unit per 15 minutes for most payers, varies). (2) Physical status modifiers (P1-P6) — some payers add units for higher physical status. (3) Qualifying circumstances — extreme age (99100), controlled hypotension (99135), hypothermia (99116) add units. (4) Direction vs supervision — medical direction (modifier QK/QY for up to 4 concurrent cases with CRNA) vs medical supervision (modifier AD for 5+ cases) affects billing rates. (5) Concurrent procedures — the anesthesiologist's reimbursement varies based on how many cases they are directing simultaneously. (6) Post-anesthesia care — recovery room management is included in the anesthesia service and not separately billable.

Lab billing uniqueness: high-volume low-dollar claims where small errors scale to massive losses, medical necessity NCD/LCD validation, panel vs component coding decisions, PAMA fee cuts, ABN management, and client billing for referred specimens.

Lab and pathology billing uniqueness: (1) High-volume, low-dollar claims — labs process hundreds to thousands of claims daily at $5-$200 per test, making individual claim errors invisible but catastrophic at scale ($4 error × 800 claims/day = $960K/year), (2) Medical necessity validation — every lab test must have an ICD-10 diagnosis that meets the NCD/LCD coverage criteria for that specific test or it triggers a CO-50 denial, (3) Panel vs component billing — comprehensive metabolic panels (80053) vs individual components have different reimbursement that swings revenue 25-40%, (4) PAMA fee schedule — the Protecting Access to Medicare Act reduced clinical lab test reimbursement by 10-15% since 2018 based on private payer rate reporting, (5) ABN requirements — labs must obtain ABNs before performing non-covered tests or absorb the cost, (6) Client billing complexity — reference labs must manage both patient/payer billing and client (physician office) billing for referred specimens.

Sleep medicine billing complexity: PSG technical/professional component separation, home sleep test vs in-lab study tiers, CPAP/DME channel billing, split-night study criteria (AHI ≥20 in first 2 hours), MSLT requirements, and oral appliance billing pathways.

Sleep medicine billing complexity: (1) Technical and professional component separation — polysomnography (PSG) has facility/technical charges (TC) and physician interpretation (26) billed separately, (2) Home sleep testing vs in-lab study — HST (95800-95801) and PSG (95810-95811) have different coverage tiers, with most payers requiring HST first for uncomplicated suspected OSA, (3) CPAP/DME billing — positive airway pressure devices, masks, and supplies are billed through DME channels with specific HCPCS codes and coverage criteria, (4) Split-night studies — 95811 (PSG with CPAP titration) has specific criteria: diagnostic portion must show AHI ≥20 in the first 2 hours before switching to titration, (5) Multiple sleep latency testing (MSLT) — 95805 for narcolepsy evaluation requires preceding overnight PSG, and (6) Oral appliance therapy — dental device fitting and follow-up have limited medical billing pathways.

Wound care billing complexity: debridement code category selection (selective vs surgical), wound measurement documentation at every visit, NPWT coordination, skin substitute Q-code billing, HBOT qualifying diagnosis criteria, and multi-provider coordination.

Wound care billing complexity: (1) Multiple debridement code categories — selective (97597-97598 by wound area), non-selective (97602), and surgical debridement (11042-11047 by tissue depth and wound area) — choosing the wrong category significantly impacts reimbursement, (2) Wound measurement documentation — every wound must be measured (length × width × depth in cm) at every visit, with wound bed description, drainage, and surrounding tissue assessment, (3) Negative pressure wound therapy (NPWT) — application codes, supply codes, and DME rental codes must be coordinated, (4) Skin substitutes and grafts — cellular/tissue-based products (CTPs) have specific HCPCS Q-codes with application technique codes and per-square-centimeter billing, (5) Hyperbaric oxygen therapy (HBOT) — 99183 requires documented wound type qualifying for coverage (diabetic foot ulcer, chronic refractory osteomyelitis, compromised flaps/grafts), and (6) Multi-provider coordination — wound care often involves surgeons, primary care, and home health with overlapping billing.

Home health billing uniqueness: PDGM case-mix payment model, 30-day payment periods, OASIS assessment-driven grouping, face-to-face encounter requirement, homebound status documentation, and therapy visit functional scoring.

Home health billing uniqueness: (1) PDGM (Patient-Driven Groupings Model) — Medicare home health uses a case-mix system that groups patients into payment categories based on clinical characteristics, functional status, and comorbidities, not visit counts, (2) 30-day payment periods — replaced the old 60-day episode, with each period receiving a separate case-mix adjusted payment, (3) OASIS assessment — the Outcome and Assessment Information Set (OASIS) assessment drives the payment grouping and must be completed accurately to receive appropriate reimbursement, (4) Face-to-face encounter requirement — Medicare requires a physician face-to-face encounter documenting homebound status and skilled care need before certifying the home health plan, (5) Homebound status documentation — the patient must be homebound (leaving home requires considerable effort or is medically contraindicated) and this must be documented at every certification, and (6) Therapy thresholds — under PDGM, therapy visits no longer drive payment directly but affect functional scoring.

Telemedicine billing: modifier 95 + POS 02/10 for audio-video visits, modifier 93 for audio-only (if covered), Q3014 originating site facility fee, geographic restrictions for Medicare, state licensure requirements, and HIPAA-compliant platform documentation.

Telemedicine billing: (1) Modifier 95 and POS code — append modifier 95 to E/M codes (99202-99215) for synchronous audio-video telemedicine visits, with Place of Service 02 (telehealth) or 10 (patient home), (2) Audio-only visits — 99441-99443 (telephone E/M) or standard E/M with modifier 93 (audio-only when permitted by payer) — coverage varies significantly by payer and state, (3) Originating site facility fee — Medicare pays a facility fee to the originating site (where the patient is located) using HCPCS Q3014, (4) Geographic restrictions — Medicare historically required the patient to be in a rural area and at an eligible originating site, though COVID-era flexibilities expanded access and some have been made permanent, (5) State licensure — the provider must be licensed in the state where the patient is physically located at the time of the visit, and (6) Technology requirements — HIPAA-compliant audio-video platform required for modifier 95 billing; documentation must note the modality used.

OT billing differences from PT: separate $2,410 therapy cap, unique codes for self-care (97535), work reintegration (97537), OTA 85% rate with CQ modifier, ADL-focused documentation, mental health OT coverage, and hand therapy specialization coding.

OT vs PT billing differences: (1) Separate therapy cap — OT has its own $2,410 Medicare therapy cap (2025), separate from the combined PT/SLP cap. (2) Different CPT codes — while OT shares some codes with PT (97110 therapeutic exercise, 97530 therapeutic activities), OT has unique codes for self-care/home management training (97535), community/work reintegration (97537), and wheelchair management (97542). (3) OTA supervision rules — OT assistants (OTAs) bill at 85% of the OT rate under Medicare with CQ modifier, similar to PTAs but with separate supervision requirements. (4) Documentation focus — OT documentation emphasizes ADL (Activities of Daily Living) functional outcomes rather than mobility and strength measures that dominate PT notes. (5) Mental health OT — occupational therapy for mental health conditions (anxiety, PTSD affecting daily function) has different coverage criteria and documentation requirements. (6) Hand therapy — certified hand therapists (CHTs) bill using standard OT evaluation and treatment codes with specialized documentation.

SLP billing uniqueness: shared therapy cap with PT ($2,410 combined), unique evaluation codes (92521-92524), swallowing evaluation and treatment codes (92610-92611, 92526), cognitive-communication documentation requirements, and AAC device evaluation coding.

SLP billing uniqueness: (1) Shared therapy cap with PT — SLP shares the $2,410 combined therapy cap with physical therapy under Medicare, meaning high-utilization PT patients may leave limited cap space for SLP services. (2) Unique evaluation codes — 92521 (fluency), 92522 (speech sound production), 92523 (speech sound production + language comprehension/expression), 92524 (voice and resonance). (3) Swallowing evaluation and treatment — 92610 (clinical swallowing evaluation), 92611 (motion fluoroscopic swallowing study), 92526 (treatment of swallowing dysfunction) are high-frequency codes unique to SLP. (4) Cognitive-communication — 92507 (treatment of speech, language, voice, communication, auditory processing) covers cognitive-linguistic therapy but requires documentation linking cognitive deficits to communication function. (5) Augmentative and alternative communication (AAC) — device evaluation (92607-92608) and DME billing for AAC devices. (6) Pediatric-specific coding — early intervention services may use different billing pathways.

Sports medicine billing complexity: multi-discipline provider billing authority, athletic trainer incident-to requirements, diverse procedure coding, workers comp/personal injury payers, non-covered regenerative therapy separation, and medical treatment vs performance optimization boundaries.

Sports medicine/rehab billing complexity: (1) Multi-discipline coordination — sports medicine practices may include physicians, physical therapists, athletic trainers, and exercise physiologists, each with different billing authority and supervision requirements. (2) Athletic trainer billing — ATs cannot bill Medicare directly and have limited commercial payer recognition; services often must be billed incident-to a physician. (3) Procedure diversity — from office E/M visits and joint injections to arthroscopic surgery, PRP/stem cell injections (often non-covered), concussion management protocols, and rehabilitation services. (4) Workers compensation and personal injury — sports injuries frequently involve third-party payers with different documentation, authorization, and fee schedule requirements. (5) Non-covered regenerative therapies — platelet-rich plasma (PRP), stem cell injections, and prolotherapy are typically patient-pay and must be clearly separated from covered services. (6) Performance optimization vs medical treatment — payer boundary between treating a medical condition and enhancing athletic performance affects coverage.

Geriatric billing uniqueness: Annual Wellness Visit (G0438/G0439), chronic care management (99490/99491), advance care planning (99497/99498), cognitive assessment (99483), transitional care management (99495/99496), and home visit codes (99341-99350).

Geriatric billing uniqueness: (1) Annual Wellness Visit (AWV) — Medicare covers an annual wellness visit (G0438 initial, G0439 subsequent) that is separate from the standard E/M visit; billing both on the same day requires modifier 25 and a distinct medical problem, (2) Chronic care management (CCM) — geriatric patients with 2+ chronic conditions qualify for monthly CCM codes (99490, 99491) generating recurring revenue for care coordination, (3) Advance care planning (ACP) — 99497 (first 30 minutes) and 99498 (each additional 30 minutes) are separately billable when discussing advance directives, living wills, and end-of-life care preferences, (4) Cognitive assessment — 99483 (cognitive assessment and care planning) is a high-RVU code for dementia evaluation, (5) Transitional care management (TCM) — 99495/99496 for post-discharge care coordination pays well but has strict timing requirements (contact within 2 business days, face-to-face within 7 or 14 days), and (6) Home visit codes (99341-99350) for patients unable to visit the office.

Emergency medicine billing uniqueness: ED-specific E/M codes (99281-99285), no new/established distinction, critical care time documentation, separate professional vs facility billing, observation status coding, and trauma activation fees.

Emergency medicine billing uniqueness: (1) Specific E/M code set — ED visits use 99281-99285 (not standard office E/M codes), based on complexity of medical decision-making and severity of presenting problem, (2) No established/new patient distinction — all ED patients use the same code set regardless of whether they have been seen before, (3) Critical care billing — 99291 (first 30-74 minutes) and 99292 (each additional 30 minutes) are frequently billed in EDs for critically ill patients, with specific time documentation and procedure bundling rules, (4) Facility vs professional billing — ED physician professional charges are separate from the hospital facility charges for the same visit, (5) Observation status billing — patients placed in observation use specific codes (99218-99220 for initial, 99224-99226 for subsequent, 99217 for discharge), and (6) Trauma activation fees — separately billable by the hospital with specific activation criteria.

Pediatric billing uniqueness: age-specific well-child visit codes, complex vaccine administration coding (20+ vaccines), VFC program billing rules, developmental screening codes, newborn/NICU specialized coding, and pediatric chronic care management.

Pediatric billing uniqueness: (1) Well-child visit codes — preventive visits use age-specific codes: 99381-99385 (new patient by age group) and 99391-99395 (established patient by age group), separate from problem-oriented E/M codes, (2) Vaccine administration complexity — pediatric practices administer 20+ vaccines through age 18, with separate codes for vaccine product and administration (90460-90461 with counseling for <19, 90471-90474 without counseling), (3) VFC (Vaccines for Children) program — federally funded vaccines for eligible children must be billed with specific administration codes and cannot include vaccine product charges for VFC-eligible patients, (4) Developmental screening — standardized screening codes (96110 developmental, 96127 emotional/behavioral) are separately billable during well-child visits, (5) Newborn care — initial newborn care (99460-99463), subsequent nursery care (99462), and NICU care have specialized coding, and (6) Chronic care management — pediatric CCM for complex conditions (asthma, diabetes, ADHD) generates additional monthly revenue.

Orthopedic billing complexity includes high-value surgical coding, 90-day global period management, fracture care classification, multi-procedure modifier usage, implant/hardware billing, and workers compensation fee schedule management.

Orthopedic billing complexity stems from: (1) High surgical volume — joint replacements, arthroscopy, fracture repair, and spine surgery generate $5,000-$80,000+ per case requiring precise coding, (2) Global surgical periods — most orthopedic procedures carry 90-day global periods during which post-operative care is bundled, (3) Fracture care coding — fracture care is divided into initial treatment (with or without manipulation), type of fracture fixation (closed vs open reduction), and follow-up within the global period, (4) Multiple procedure coding — bilateral joint replacements, multi-level spine surgery, and combined arthroscopic procedures require careful modifier usage (50, 51, 59/XS), (5) Implant billing — prosthetic joints, fixation hardware, and bone substitutes are billed separately with specific HCPCS codes, and (6) Workers compensation — orthopedic practices see significant workers comp volume with different fee schedules and authorization requirements.

Infectious disease billing uniqueness: consultation-heavy coding, OPAT antibiotic management coordination, complex E/M documentation, antimicrobial stewardship billing challenges, travel medicine patient-pay services, chronic viral disease management, and infection antibiotic coordination.

Infectious disease billing uniqueness: (1) Consultation-heavy practice — ID physicians frequently provide inpatient consultations (99252-99255) with detailed documentation of requesting physician, clinical question, findings, and recommendations, (2) Prolonged antibiotic management — outpatient parenteral antibiotic therapy (OPAT) involves drug selection, dosing, monitoring, and coordination with infusion centers or home health, creating multiple billing touchpoints, (3) Complex E/M documentation — ID cases involve extensive history review, lab/culture interpretation, and antimicrobial stewardship decisions supporting high-complexity medical decision-making, (4) Antimicrobial stewardship — ID physicians providing stewardship consultations may not have a separate patient encounter to bill, creating revenue challenges, (5) Travel medicine — pre-travel consultations and vaccination programs may be patient-pay, (6) HIV/Hepatitis management — chronic viral disease management with complex antiretroviral/antiviral regimens, resistance testing, and prior authorization for specialty medications, and (7) Wound and prosthetic joint infection management — long-term antibiotic coordination.

Hematology billing complexity: oncology code overlap for malignancies, transfusion medicine coding, bone marrow aspiration/biopsy procedures, anticoagulation management, iron and biologic infusion coding, and flow cytometry panel documentation.

Hematology billing complexity: (1) Overlap with oncology — hematologic malignancies (leukemia, lymphoma, myeloma) use the same chemotherapy administration and drug billing codes as medical oncology, (2) Transfusion medicine — blood product administration codes (36430 for whole blood, 36440 for push transfusion, 86900-86999 for blood typing and crossmatching) with specific documentation of units, product type, and clinical indication, (3) Bone marrow procedures — aspiration (38220) and biopsy (38221) can be billed together when performed at different sites, with pathology interpretation separately billable, (4) Coagulation management — anticoagulation therapy management (99363-99364, now reported as standard E/M) and INR testing (85610) have transitioned to standard E/M coding, (5) Infusion therapy — iron infusion (96365-96368 with J1756 for iron dextran, J1439 for ferric carboxymaltose), erythropoiesis-stimulating agents, and other biologic infusions, and (6) Flow cytometry — 88184-88189 for immunophenotyping with specific panel and marker documentation.

Radiology billing complexity: TC/26 component separation, multiple procedure TC reduction, contrast administration coding, radiology benefit manager prior authorization, ACR Appropriateness Criteria alignment, and PACS/RIS billing system integration.

Radiology billing complexity: (1) Technical and professional component separation — every imaging study has a TC (technical: equipment, technologist, facility) and 26 (professional: physician interpretation and report), billed separately or globally depending on the practice setting, (2) Multiple procedure reduction — second and subsequent imaging studies of the same body area on the same day are reduced by 50% for the TC component, (3) Contrast administration — imaging with contrast (CT, MRI, fluoroscopy) requires separate documentation of contrast type, route, and clinical indication, with specific code selection for with/without contrast studies, (4) Prior authorization — advanced imaging (CT, MRI, PET) typically requires prior auth through radiology benefit managers (eviCore, AIM Specialty Health) with documented clinical indication, (5) ACR Appropriateness Criteria — imaging orders that do not align with American College of Radiology guidelines face higher denial rates, and (6) PACS/RIS integration — billing systems must accurately capture the study performed, reading physician, and technical details from PACS/RIS systems.

Genetic testing billing complexity: rapidly evolving CPT codes, narrow LCD/NCD coverage criteria, extensive CGP prior authorization, unlisted code documentation, LDT regulatory considerations, high patient financial exposure, and companion diagnostic coverage linkage.

Genetic testing billing complexity: (1) Rapidly evolving code landscape — molecular pathology codes (81161-81479) and genomic sequencing codes (81410-81471) are updated frequently as new tests emerge, (2) LCD/NCD coverage limitations — many genetic tests have narrow coverage criteria defined by Local Coverage Determinations, with significant variation between Medicare contractors, (3) Prior authorization burden — comprehensive genomic profiling (CGP) tests like FoundationOne, Tempus, and Guardant require extensive prior authorization with documented clinical utility, (4) Unlisted codes — new genetic tests without specific CPT codes must use unlisted codes (81479, 81599) with comparison code documentation and detailed test descriptions, (5) Lab-developed tests (LDTs) — internally developed genetic assays have different billing pathways and regulatory considerations, (6) Patient financial exposure — many genetic tests cost $1,000-$10,000+ and may not be covered, requiring careful pre-test cost conversations and ABN documentation, and (7) Companion diagnostic requirements — some genetic tests are only covered when linked to specific FDA-approved targeted therapies.

Thoracic surgery billing complexity: high-value procedure coding, VATS vs open approach code selection, multi-procedure bundling, co-surgeon modifier 62, 90-day global period management, device/implant billing, and lung transplant coding.

Thoracic surgery billing complexity: (1) High-value procedures — lung resections (32480-32505), esophagectomy (43107-43124), and mediastinal surgery generate $5,000-$50,000+ per case with complex coding, (2) VATS vs open approach — video-assisted thoracoscopic surgery codes are different from open thoracotomy codes and reimburse differently, (3) Multiple procedure coding — thoracic cases often combine diagnostic (biopsy, mediastinoscopy) with therapeutic procedures requiring careful bundling analysis, (4) Co-surgeon billing — complex esophageal and tracheal procedures often require two surgeons with modifier 62 documentation, (5) 90-day global periods — major thoracic procedures include extensive post-operative management in the global package, (6) Implant/prosthetic billing — esophageal stents, chest tubes, and other devices billed separately, and (7) Lung transplant — complex pre-transplant evaluation, procurement, and post-transplant management coding.

FQHC billing uniqueness: PPS per-visit encounter rate (~$190-$210), qualifying visit/provider definitions, same-day billing restrictions, FQHC-specific HCPCS codes (G0466-G0470), sliding fee scale collections, and 340B drug pricing management.

FQHC billing uniqueness: (1) Prospective Payment System (PPS) — FQHCs receive a per-visit encounter rate from Medicare (~$190-$210 per visit) rather than fee-for-service reimbursement, regardless of the number of services provided during the visit, (2) Qualifying visit definition — only face-to-face visits with qualifying providers (physicians, NPs, PAs, CNMs, clinical psychologists, clinical social workers) count as billable encounters, (3) Same-day billing restrictions — generally only one visit per day per patient per discipline is billable, except for specific exceptions (mental health + medical on same day with different providers), (4) FQHC-specific HCPCS codes — G0466 (new patient), G0467 (established patient), G0468 (initial preventive), G0469 (subsequent preventive), G0470 (mental health), (5) Sliding fee scale — FQHCs must offer discounted services based on ability to pay, affecting collections, (6) 340B drug pricing — FQHCs purchase drugs at 340B discounted prices but must manage separate inventory and prevent duplicate discounts.

Clinical research billing complexity: coverage analysis separating qualifying vs non-qualifying services, Medicare NCD 310.1 for routine trial costs, Z00.6 coding for trial participants, budget negotiation, billing compliance, and informed consent cost alignment.

Clinical research billing complexity: (1) Coverage Analysis — every clinical trial protocol requires a coverage analysis separating qualifying (standard of care) services from non-qualifying (research-specific) services, with qualifying services billed to insurance and non-qualifying billed to the sponsor, (2) Medicare Clinical Trial Policy — Medicare covers routine costs of qualifying clinical trials (NCD 310.1), including items/services typically provided absent a trial, diagnosis/treatment of complications, and conventional care alternatives, (3) ICD-10 coding — research participants require Z00.6 (encounter for examination for normal comparison and control in clinical research program) as secondary diagnosis to identify clinical trial claims, (4) Budget negotiation — site budgets must cover all non-covered items plus fair market value for investigator time, coordinator time, and overhead, (5) Billing compliance — incorrectly billing sponsors for covered services or insurers for research-only services constitutes fraud, and (6) Informed consent alignment — the informed consent must accurately reflect which costs are borne by the patient/insurance vs the sponsor.

DME billing uniqueness: HCPCS Level II coding, Certificate of Medical Necessity requirements, rental vs purchase models, competitive bidding pricing, ABN requirements, DMEPOS accreditation, and prior authorization for high-cost equipment.

DME billing uniqueness: (1) HCPCS Level II coding — DME uses HCPCS codes (E, K, L, A series) rather than CPT codes, with specific code selection based on device type, features, and patient qualification, (2) Certificate of Medical Necessity (CMN) — most DME requires a physician-completed CMN documenting the medical need, diagnosis, and device specifications, (3) Rental vs purchase — some DME (oxygen equipment, hospital beds, wheelchairs) is rented for 13 months then transferred to the patient, while other items are purchased outright, (4) Competitive bidding — Medicare DME prices in competitive bidding areas are set through the DMEPOS Competitive Bidding Program, often at 30-50% below fee schedule rates, (5) ABN requirements — when coverage is uncertain, the supplier must obtain an ABN before providing the item, (6) DMEPOS supplier accreditation — Medicare requires accreditation (by organizations like ACHC, The Compliance Team, or HQAA) to bill DME, and (7) Prior authorization for power wheelchairs, CPAP, and other high-cost items.

Primary care billing challenges: E/M level accuracy (99213 vs 99214 = $50K-$100K annual impact), preventive vs problem visit separation, CCM revenue opportunity, MIPS quality adjustments, vaccine administration coding, and chronic disease monitoring codes.

Primary care billing challenges: (1) E/M level selection — choosing between 99213 (moderate) and 99214 (moderate-high) on every visit, where the difference is $30-$50 per visit and systematic downcoding costs a typical practice $50,000-$100,000 annually, (2) Preventive vs problem-oriented visits — annual physicals (99381-99397) and Medicare AWV (G0438/G0439) cannot be billed with same-day E/M unless a separately identifiable problem is documented with modifier 25, (3) Chronic care management (CCM) — 99490/99491 for patients with 2+ chronic conditions generates $40-$80/patient/month in additional revenue but requires documented time and care coordination activities, (4) Quality payment programs — MIPS (Merit-based Incentive Payment System) adjustments can increase or decrease Medicare payments by up to 9% based on quality measures, cost, improvement activities, and promoting interoperability, (5) Vaccine administration — separate codes for administration (90471-90474) and the vaccine product, and (6) Care plan oversight and remote monitoring codes for chronic disease management.

Pharmacy billing uniqueness: NDC-based coding, real-time PBM adjudication, MAC generic pricing, DIR retroactive fee adjustments, 340B program compliance, specialty pharmacy coordination, and compound prescription ingredient billing.

Pharmacy billing uniqueness: (1) NDC-based billing — pharmacy claims use National Drug Codes (NDC) rather than CPT/HCPCS codes, with 11-digit format identifying manufacturer, product, and package size, (2) PBM (Pharmacy Benefit Manager) adjudication — claims are processed in real-time through PBMs (Express Scripts, CVS Caremark, OptumRx) using NCPDP (National Council for Prescription Drug Programs) format, (3) MAC (Maximum Allowable Cost) pricing — PBMs set MAC prices for generics that may fall below acquisition cost, creating negative margins on some drugs, (4) DIR (Direct and Indirect Remuneration) fees — retroactive fees charged by PBMs that reduce effective reimbursement below the point-of-sale price, (5) 340B program billing — eligible entities purchase drugs at steep discounts but must maintain separate inventory tracking and comply with duplicate discount prohibition, (6) Specialty pharmacy — high-cost medications ($1,000+/month) with complex prior authorization, limited distribution, and patient assistance program coordination, and (7) Compound prescriptions — billing based on ingredient costs plus professional fee.

PT billing complexity stems from therapy caps ($2,410 for 2025), time-based coding with the 8-minute rule, plan of care certification requirements, PTA supervision/modifier rules, and frequent re-authorization needs.

Physical therapy billing is unique because of several factors: (1) Medicare therapy caps — the 2025 combined therapy cap is $2,410 for PT and SLP combined, requiring KX modifier once exceeded and documentation to justify medical necessity, (2) Time-based CPT codes — most therapeutic procedure codes (97110, 97140, 97530, etc.) are billed in 15-minute units using the 8-minute rule, (3) Functional limitation reporting (FOTO/G-codes replacement with functional outcome measures), (4) Plan of care requirements — Medicare requires a certified plan of care signed by the referring physician every 90 days, (5) Supervision requirements — PTAs bill at 85% of the PT rate under Medicare, requiring correct modifier usage (CQ modifier for PTA services), and (6) Prior authorization requirements vary significantly by payer, with many commercial plans requiring re-authorization every 12-20 visits.

Urology billing complexity includes wide procedural range across settings, bilateral modifier usage (50), multiple procedure coding, 90-day global periods, site-of-service differentials, implant billing, and E/M plus procedure modifier management.

Urology billing complexity stems from: (1) Wide procedural range — from office-based cystoscopies ($200-$400) to robotic-assisted prostatectomies ($15,000+), requiring coding expertise across outpatient and surgical settings, (2) Multiple procedure modifiers — urologic procedures frequently involve bilateral structures (kidneys, ureters) requiring modifier 50, and multiple procedures during the same session requiring modifiers 51 and 59/XS, (3) Global surgical periods — major urologic surgeries carry 90-day globals with complex post-op visit management, (4) Site-of-service differentials — many urologic procedures can be performed in office, ASC, or hospital settings with significantly different reimbursement, (5) Implant and device billing for penile prostheses, ureteral stents, and artificial urinary sphincters, and (6) E/M integration — many urologic visits combine evaluation with in-office procedures (cystoscopy, prostate biopsy) requiring careful modifier 25 usage.

ENT billing complexity includes dual medical-surgical coding, multiple procedure bundling for combined surgeries, endoscopy code hierarchy, audiometric testing components, allergy testing requirements, and significant site-of-service differentials.

ENT billing complexity arises from: (1) Dual medical-surgical nature — ENT practices bill both office E/M visits and complex surgical procedures, often on the same day requiring modifier 25, (2) Multiple procedure coding — many ENT surgeries involve multiple anatomic sites in the same session (septoplasty + turbinate reduction + sinus surgery), (3) Endoscopy code hierarchy — nasal/laryngeal endoscopy codes have specific bundling rules where the most comprehensive code includes lesser procedures, (4) Hearing and balance testing — audiometric testing has both professional and technical components with specific staffing requirements, (5) Allergy testing and immunotherapy — extensive coding requirements for skin prick testing, intradermal testing, and injection billing, (6) Global period management for surgical cases with 90-day post-op inclusion, and (7) Significant site-of-service implications — many ENT procedures transitioned from hospital to office or ASC settings.

Oncology billing complexity includes chemotherapy infusion timing codes, HCPCS drug unit calculations, buy-and-bill inventory management, radiation therapy planning codes, clinical trial billing separation, and molecular testing authorization.

Oncology billing is among the most complex in healthcare: (1) Drug administration coding — chemotherapy infusion codes (96413-96417) have specific timing rules: 96413 for the first hour of the first drug, 96415 for each additional hour, 96417 for each additional sequential drug — incorrect timing leads to systematic underpayment, (2) Drug billing — oncology drugs are billed using HCPCS J-codes with specific unit calculations (e.g., J9271 for pembrolizumab is per 1mg, so a 200mg dose = 200 units), (3) Buy-and-bill model — practices purchase drugs and bill payers, creating significant cash flow and inventory management requirements, (4) Radiation therapy — complex treatment planning codes, daily treatment delivery, and weekly management codes, (5) Clinical trial billing — qualifying vs non-qualifying services must be separated, (6) Molecular/genetic testing — complex prior authorization and LCD coverage requirements for biomarker testing.

Nephrology billing uniqueness: monthly capitated dialysis payments (90960-90962), separate facility vs physician billing, ESRD PPS bundling rules, vascular access procedure coding, transplant management timelines, and AKI hospital management coding.

Nephrology billing has unique characteristics: (1) Monthly Capitated Payment (MCP) for dialysis — Medicare pays nephrologists a monthly fee (90960-90962) based on the number of face-to-face visits per month (4+, 2-3, or 1 visit), replacing per-visit billing, (2) Dialysis facility vs physician billing — facility claims (72x revenue codes) are separate from physician professional claims, (3) ESRD PPS (Prospective Payment System) — Medicare bundles most lab tests and drugs into the facility payment, but certain separately billable items require specific modifiers, (4) Vascular access procedures — creation, revision, and monitoring of AV fistulas, grafts, and catheters have complex coding, (5) Transplant management — pre- and post-transplant care has specific billing codes and timelines, and (6) Acute kidney injury management in hospital settings uses critical care and subsequent hospital care codes with specific documentation requirements.

Rheumatology billing complexity: high-cost biologic drug administration ($5K-$25K/infusion), joint injection modifier management, extensive biologic prior authorization with step therapy, complex E/M documentation, and disease activity score requirements.

Rheumatology billing complexity includes: (1) High-cost biologic medications — infusion drugs like infliximab (Remicade) and rituximab cost $5,000-$25,000 per infusion, requiring precise J-code billing and buy-and-bill inventory management, (2) Joint injection coding — multiple injection sites in a single visit require correct modifier usage (different anatomic sites) and documentation of each injection separately, (3) Extensive prior authorization — virtually every biologic requires step therapy documentation showing failed conventional DMARDs before approval, (4) E/M complexity — rheumatologic conditions require detailed multi-system examinations with complex medical decision-making, often supporting level 4-5 visits, (5) Overlap with other specialties — rheumatology shares diagnosis codes with orthopedics, dermatology, and pulmonology, creating coordination challenges, and (6) Disease activity scoring — many payers require documented disease activity scores (DAS28, CDAI, HAQ) to justify continued biologic therapy.

Pulmonology billing complexity: PFT interpretation requirements, bronchoscopy add-on code management, sleep study component billing, critical care time documentation, oxygen qualifying criteria, and pulmonary rehabilitation medical necessity.

Pulmonology billing complexity includes: (1) Pulmonary function testing (PFT) — spirometry (94010), lung volumes (94726), DLCO (94729), and bronchoprovocation (94070) each have specific documentation and interpretation requirements, (2) Bronchoscopy procedures — multiple add-on codes for biopsy, lavage, stent placement, and navigational bronchoscopy performed in the same session, (3) Sleep medicine — polysomnography (95810-95811) and home sleep testing (95800-95801) have specific technical and professional component billing, (4) Critical care billing — pulmonologists frequently provide critical care (99291-99292) with complex time-based documentation and procedure bundling rules, (5) Oxygen and DME — home oxygen prescriptions require specific qualifying criteria documentation (PaO2 ≤55 or SpO2 ≤88%), and (6) Pulmonary rehabilitation — programs require comprehensive documentation of medical necessity and functional improvement.

Ophthalmology billing complexity: high-volume diagnostic testing (OCT, visual fields), cataract surgery IOL billing, 90-day surgical globals, refraction ABN requirements, medical vs routine exam distinction, and retinal procedure modifier management.

Ophthalmology billing is complex due to: (1) High-volume diagnostic testing — a single office visit may include 5-10 separately billable tests (OCT, visual fields, fundus photography, gonioscopy, pachymetry), each requiring separate documentation and medical necessity, (2) Surgical procedures — cataract surgery (66984) is the most performed surgery in the US, with complex IOL billing (V2632 for standard, V2787 for premium), ASC vs hospital differential coding, and bilateral modifier management, (3) Global surgical periods — cataract surgery has a 90-day global during which most post-op care is bundled, (4) Refraction (92015) — not covered by Medicare and requires ABN documentation, (5) Medical vs routine eye exam distinction — 92012/92014 (medical) vs 92002/92004 (now deleted) vs routine refraction-only visits, and (6) Retinal procedures — intravitreal injections (67028) and laser treatments have specific bilateral and multiple procedure rules.

Pain management billing complexity: interventional procedure level-specific coding, imaging guidance add-on codes, multi-level injection modifier management, drug testing frequency limits, complex E/M documentation, and extensive prior authorization requirements.

Pain management billing complexity includes: (1) Interventional procedure coding — epidural steroid injections, facet joint blocks, nerve blocks, and spinal cord stimulator trials have intricate code selection based on anatomic level and approach, (2) Fluoroscopy and imaging guidance — most interventional pain procedures require imaging guidance (77003 fluoroscopy, 76942 ultrasound, 77012 CT) billed as add-on codes, (3) Multiple procedure sessions — pain management often involves injections at multiple spinal levels in the same session, requiring level-specific documentation and correct modifier usage, (4) Drug testing — urine drug screening (80305-80307) has specific coverage criteria and frequency limits, (5) E/M intensity — pain management E/M visits involve complex medical decision-making with opioid risk assessment, medication management, and treatment planning, and (6) Prior authorization — virtually all interventional procedures require pre-authorization with documented conservative treatment failure.

Allergy billing uniqueness: high-volume skin testing (40-80 tests/visit), immunotherapy preparation and injection coding, component vs panel IgE testing, biologic drug administration, pulmonary function testing, and patch testing billing rules.

Allergy billing uniqueness: (1) Allergy testing volume — a single patient visit may involve 40-80 skin prick tests (95004) and 20-40 intradermal tests (95024), creating high-volume but low-per-test reimbursement, (2) Immunotherapy billing — allergy shot preparation (95165) and injection administration (95115/95117) are separate codes with specific unit and dose documentation, (3) Component testing — allergen-specific IgE (86003) and multi-allergen panel (86005) codes have different reimbursement structures, (4) Biologic medications — omalizumab (Xolair) and dupilumab (Dupixent) for allergic conditions require drug administration coding and buy-and-bill management, (5) Pulmonary function testing — many allergists perform spirometry (94010/94060) and challenge testing (94070) requiring technical competency documentation, and (6) Patch testing (95044) for contact dermatitis has specific application and reading visit billing rules.

Endocrinology billing uniqueness: complex E/M for multi-system conditions, chronic care management eligibility, CGM professional services, insulin pump management coding, in-office FNA and ultrasound, DEXA frequency limits, and extensive drug management.

Endocrinology billing uniqueness: (1) Complex E/M documentation — endocrine conditions (diabetes, thyroid disorders, adrenal insufficiency, pituitary tumors) require detailed multi-system exams and complex medical decision-making supporting level 4-5 visits, (2) Chronic care management (CCM) — diabetes and other endocrine conditions qualify for monthly CCM codes (99490, 99491) for care coordination between visits, (3) Continuous glucose monitoring (CGM) — professional CGM placement and interpretation (95249-95251) and remote therapeutic monitoring codes, (4) Insulin pump management — pump initiation, training, and ongoing management have specific coding requirements, (5) Thyroid procedures — fine needle aspiration (FNA) of thyroid nodules (10005-10012) and thyroid ultrasound (76536) are commonly performed in-office, (6) Bone density testing — DEXA scans (77080-77081) have frequency limits and specific covered diagnoses, and (7) Drug management complexity — insulin regimen adjustments, GLP-1 agonist authorizations, and growth hormone therapy monitoring.

OB/GYN billing complexity: global obstetric package bundling, antepartum care unbundling for transfers, hysterectomy approach-specific coding, modifier 22 for increased complexity, pregnancy vs gynecologic diagnosis coverage differences, and split preventive/problem billing.

OB/GYN billing complexity stems from: (1) Global obstetric package — prenatal, delivery, and postpartum care are bundled into a single global code (59400, 59510, 59610, 59618) with strict rules about what is and is not included, (2) Antepartum care unbundling — when a patient transfers care or delivers prematurely, antepartum visits must be unbundled using 59425/59426 based on visit count, (3) Gynecologic surgery — hysterectomy coding varies by approach (abdominal, vaginal, laparoscopic, robotic) and by whether the uterus weighs more or less than 250g, (4) Modifier complexity — many GYN procedures require modifier 22 (increased procedural services) for unusual circumstances like extensive adhesions or enlarged uterus, (5) Maternity vs gynecologic diagnosis distinction — ICD-10 chapter 15 (O-codes) for pregnancy-related services have different coverage rules than general gynecologic diagnoses, and (6) Preventive care integration — well-woman exams may include both preventive and problem-oriented components requiring split billing.

Neurosurgery billing complexity: high-value multi-level spine coding, co-surgeon/assistant modifier management, spinal implant device billing, 90-day global period management, and intraoperative neuromonitoring coding.

Neurosurgery billing complexity: (1) High-value procedures — spine surgery, craniotomies, and neurostimulator implantation generate $10,000-$100,000+ per case with complex coding, (2) Multiple procedure coding — spine surgery commonly involves multiple levels, approaches (anterior, posterior, lateral), and techniques (decompression, fusion, instrumentation) billed as separate codes, (3) Co-surgeon and assistant surgeon modifiers — modifier 62 (co-surgeons) and modifier 80/82 (assistant surgeon) are common for complex spine and cranial cases, (4) Implant/device billing — spinal hardware (pedicle screws, interbody cages, rods) and neurostimulators are billed separately with specific HCPCS codes, (5) 90-day global periods — major neurosurgical procedures have complex post-operative care management, and (6) Intraoperative neuromonitoring — the surgeon's involvement in monitoring has specific billing codes distinct from the monitoring technologist.

Plastic surgery billing uniqueness: reconstructive vs cosmetic determination, extensive pre-authorization documentation with photographs, WHCRA breast reconstruction mandate, unlisted procedure coding, staged procedure modifier management, and implant/device billing.

Plastic surgery billing uniqueness: (1) Reconstructive vs cosmetic distinction — the single most important billing determination: reconstructive procedures are insurance-covered when restoring function or correcting deformity from trauma, disease, or congenital anomaly; cosmetic procedures are patient-pay, (2) Documentation burden — reconstructive cases require extensive pre-authorization documentation including photographs, functional impairment description, and medical necessity letters, (3) Breast reconstruction — federal law (WHCRA) mandates insurance coverage of post-mastectomy reconstruction, including procedures on the contralateral breast for symmetry, (4) Coding complexity — many plastic surgery procedures do not have specific CPT codes, requiring unlisted procedure codes (15999, 19499) with operative report comparison to reference codes, (5) Multiple procedure sessions — staged reconstructive procedures require modifier 58 and careful global period management, and (6) Implant and tissue expander billing with specific HCPCS codes.

IR billing complexity: dual surgical/imaging component billing, vascular vs non-vascular code selection, selective catheterization order-based coding, supervision and interpretation documentation, CCI bundling analysis, and evolving combined procedure/imaging codes.

Interventional radiology billing complexity: (1) Dual-component billing — most IR procedures have both a surgical/procedural component and an imaging guidance component (fluoroscopy, CT, ultrasound), which may be billed together or separately depending on the code structure, (2) Vascular vs non-vascular coding — vascular interventions (angiography, angioplasty, stenting, embolization) and non-vascular procedures (biopsies, drainages, ablations) use different code families, (3) Selective catheterization — vascular catheterization codes (36215-36248) are based on the order of vessel selectivity (first, second, third order), with each additional vessel requiring correct add-on coding, (4) Supervision and interpretation — S&I codes are separate from the surgical codes and must be documented with written reports, (5) Bundling complexity — CCI edits bundle many imaging guidance codes into procedural codes, requiring careful analysis before billing separately, and (6) New vs revised code families — IR coding has undergone major revisions in recent years with new combined procedural/imaging codes.

Respiratory therapy billing uniqueness: incident-to physician billing requirement, procedure-based codes (94640, 94660, 94002-94004), hospital DRG bundling, ventilator management coding, home respiratory DME billing, and tracheostomy care coding.

Respiratory therapy billing uniqueness: (1) Incident-to billing — respiratory therapists (RTs) cannot bill Medicare independently; services must be billed incident-to a physician order under direct supervision, (2) Procedure-based coding — common RT codes include 94640 (nebulizer treatment), 94660 (CPAP initiation), 94662 (BiPAP), 94002-94004 (ventilator management), 94010/94060 (pulmonary function testing when performed by RT), (3) Hospital inpatient billing — most RT services in the hospital are bundled into the DRG payment and not separately billable by the hospital; the ordering physician bills professional interpretation, (4) Ventilator weaning — complex ventilator management has specific daily codes and documentation requirements, (5) Home respiratory services — home ventilator management, home nebulizer treatments, and oxygen therapy cross into DME billing territory, and (6) Tracheostomy care — tube changes and airway management coding.

Occupational health billing uniqueness: workers comp fee schedules by state, employer-direct billing for DOT/drug screen/surveillance, first report of injury requirements, treatment authorization, impairment rating coding, and OSHA-mandated service billing.

Occupational health billing uniqueness: (1) Workers compensation as primary payer — work injury/illness claims use state-specific workers comp fee schedules (not Medicare/commercial rates), with different documentation, authorization, and reporting requirements, (2) Employer-paid services — DOT physicals, pre-employment drug screens, hearing conservation programs, and surveillance exams are billed directly to employers at contracted or retail rates, not insurance, (3) First Report of Injury — every new work injury requires a state-specific first report documenting injury date, mechanism, body part, and work-relatedness, (4) Treatment authorization — many state workers comp systems require pre-authorization for treatment beyond initial visit, with specific utilization review guidelines, (5) Impairment ratings — permanent impairment evaluations use AMA Guides with state-specific modifications, billed at examination rates, (6) OSHA-mandated services — hearing tests, respiratory fit testing, and bloodborne pathogen management billed to employer, not employee or insurance.

OMS billing complexity: dual CPT/CDT coding systems, medical vs dental insurance determination, self-administered anesthesia billing, orthognathic surgery medical necessity, facial fracture coding and global periods, and TMJ procedure coverage variability.

OMS billing complexity: (1) Dual coding systems — OMS procedures may be billed using medical CPT codes (to medical insurance) or dental CDT codes (to dental insurance), and sometimes both for the same procedure depending on the clinical indication, (2) Medical vs dental coverage determination — trauma and pathology are typically medical insurance, while dental implants and extractions may be dental; orthognathic surgery may require both, (3) Anesthesia billing — OMS practitioners who administer their own anesthesia bill time-based anesthesia codes (00170 for intraoral procedures) separately from the surgical procedure, (4) Orthognathic surgery — complex jaw repositioning procedures (21141-21199) require medical necessity documentation showing functional impairment (not cosmetic), with extensive pre-authorization, (5) Fracture management — mandible and maxillary fracture coding (21310-21490) with global period management, and (6) TMJ procedures — arthroscopy (29800-29804) and open procedures with varying payer coverage.

Pathology billing complexity: specimen-based billing, TC/26 component separation, specimen level assignment (88300-88309), special stain and IHC add-on coding, molecular pathology code evolution, cytopathology screening methods, and consultation coding.

Pathology billing complexity: (1) Specimen-based billing — pathology codes are billed per specimen, not per slide or test, requiring careful correlation between specimens received and codes billed, (2) Technical and professional components — 88300-88309 (surgical pathology levels I-VI) have both TC and 26 components based on where the service is performed, (3) Specimen level assignment — each specimen must be assigned to the correct pathology level based on the tissue type (e.g., skin biopsy = level IV 88305, appendectomy = level IV 88305, lung lobectomy = level V 88307), (4) Special stains and immunohistochemistry — 88312-88319 (special stains) and 88341-88344 (immunohistochemistry) are add-on services billed per stain/antibody, (5) Molecular pathology — 81161-81479 for molecular testing with rapidly evolving codes and coverage criteria, (6) Cytopathology — Pap smear coding (88141-88175) with different codes for manual vs automated screening and physician interpretation, and (7) Consultation codes — 88321-88325 for pathology consultations with slide review.

Common sleep medicine denials: in-lab PSG without prior HST, split-night AHI criteria not met, sleep study medical necessity without documented symptoms, CPAP compliance failure for supply coverage, repeat study without clinical justification, and lab accreditation issues.

Common sleep medicine denials: **HST First Requirement:** In-lab polysomnography (95810) denied when home sleep test was not performed first — most payers require HST as the initial study for uncomplicated suspected OSA in adults. **Split-Night Criteria:** 95811 denied when diagnostic portion does not document AHI ≥20 events/hour within the first 2 hours — must document the qualifying AHI and time criteria. **Medical Necessity for PSG:** Sleep study denied without documented symptoms (excessive daytime sleepiness, witnessed apneas, unrefreshing sleep) and clinical assessment supporting sleep disorder. **CPAP Compliance:** CPAP supply replacement denied when patient does not meet compliance criteria (4+ hours/night on 70% of nights for 30 consecutive days within first 90 days). **Repeat Study Authorization:** Follow-up PSG denied without documentation of treatment failure, significant weight change, or new symptoms justifying repeat testing. **Technical Component:** TC denied when facility does not meet accreditation requirements for sleep lab.

Common wound care denials: debridement code level unsupported by documentation, missing wound measurements, skin substitute denied without 4+ weeks failed conservative care, HBOT qualifying criteria not met, visit frequency limits, and modifier 25 insufficiency.

Top wound care denials: **Debridement Code Selection:** Billing surgical debridement (11042-11047) when documentation supports only selective debridement (97597) — surgical debridement requires removal to a specific tissue depth (skin, subcutaneous, muscle, bone). **Wound Measurement Missing:** Denied when wound dimensions (L × W × D) are not documented at the current visit — previous measurements cannot be used. **Skin Substitute Coverage:** CTP/skin substitute denied without documented failed conservative wound care (4+ weeks of standard treatment), adequate blood supply, and infection control. **HBOT Qualification:** Hyperbaric oxygen denied when wound type does not meet CMS-covered conditions or when 30-day progress assessment does not show measurable improvement. **Frequency Limits:** Wound care visits denied when performed more frequently than payer allows without documented wound deterioration justifying increased frequency. **E/M with Debridement:** Modifier 25 denied when E/M is billed with debridement without separately documented evaluation and management service.

Common home health denials: face-to-face encounter documentation gaps, homebound status insufficiently described, skilled care medical necessity not demonstrated, OASIS scoring inaccuracies reducing payment, therapy goal/documentation failures, and late physician certification.

Top home health denials: **Face-to-Face Documentation:** Denied when physician face-to-face encounter documentation does not specifically address homebound status and need for skilled services — must be completed within required timeframe (90 days before or 30 days after start of care). **Homebound Status:** Denied when documentation does not adequately describe why leaving home requires considerable taxing effort or is medically contraindicated — vague statements like patient prefers to stay home are insufficient. **Medical Necessity:** Skilled nursing or therapy services denied when documentation does not show the patient requires skilled care (as opposed to custodial care that could be performed by a non-professional). **OASIS Accuracy:** Payment reduced when OASIS responses do not accurately reflect patient acuity, lowering the case-mix group and payment. **Therapy Justification:** Physical, occupational, or speech therapy visits denied when functional goals are not measurable or when documentation does not show skilled intervention versus maintenance. **Certification Period:** Claims denied when plan of care is not signed by the certifying physician within the required timeframe.

Common telemedicine denials: POS/modifier mismatch (must use POS 02/10 + modifier 95), audio-only coverage limitations, geographic restrictions, service type ineligibility, missing modality documentation, and cross-state licensure violations.

Top telemedicine denials: **Modifier/POS Mismatch:** Using POS 11 (office) instead of POS 02 (telehealth) or POS 10 (patient home), or omitting modifier 95 for synchronous audio-video visits. **Audio-Only Coverage:** Telephone E/M (99441-99443) denied by payers that do not cover audio-only visits outside of specific exceptions. **Geographic Restrictions:** Medicare denies telehealth when the patient is not at an eligible originating site or in a qualifying geographic area (check current CMS rules as these evolve). **Service Type Not Eligible:** Not all CPT codes are eligible for telemedicine delivery — check the CMS Telehealth Services List (updated quarterly) for Medicare, and verify with each commercial payer. **Documentation:** Denied when the note does not document the telemedicine modality (audio-video vs phone), platform used, and confirmation that the visit was conducted in real-time. **Cross-State Licensure:** Claims denied when the provider is not licensed in the state where the patient was located during the visit.

Common OT denials: medical necessity without measurable ADL improvement, therapy cap without KX modifier, missing functional outcome measures, OTA modifier (CQ) omission, overlap/duplication with PT services, and mental health OT coverage limitations.

Common OT denials: **Medical Necessity (CO-50):** OT denied when documentation focuses on maintenance activities rather than skilled interventions targeting measurable functional improvement in ADLs. **Therapy Cap:** Claims denied above $2,410 without KX modifier, or denied at $3,000 targeted review when documentation does not justify continued skilled OT. **ADL Documentation Gaps:** Denied when functional outcome measures are not documented — payers require standardized outcome tools showing measurable progress. **OTA Modifier Missing:** Services rendered by OTA denied without CQ modifier on Medicare claims. **Overlap with PT:** OT services denied when they duplicate PT services — documentation must clearly differentiate the OT treatment focus (ADL independence, fine motor, cognition) from PT focus (mobility, strength, gait). **Mental Health OT Coverage:** Denied by payers that do not cover OT for mental health conditions or when documentation does not link the mental health diagnosis to functional ADL limitations.

Common geriatric denials: AWV frequency violation (12-month interval), CCM time documentation gaps, TCM contact timing failures, cognitive assessment documentation insufficiency, AWV + E/M modifier 25 requirements, and advance care planning documentation.

Top geriatric denials: **AWV Frequency:** Annual Wellness Visit denied when billed within 12 months of the previous AWV — must be 12 full months between visits. **CCM Time Documentation:** 99490/99491 denied when monthly time (20 or 30 minutes minimum) is not documented with specific activities performed during the billing period. **TCM Timing:** Transitional care management denied when the initial patient contact is not made within 2 business days of discharge or face-to-face visit is not completed within the required timeframe (7 or 14 days depending on complexity). **Cognitive Assessment Documentation:** 99483 denied without comprehensive cognitive testing results, functional assessment, care plan development, and documented caregiver consultation. **AWV + E/M Same Day:** E/M billed with AWV denied without modifier 25 and a separately documented medical problem that is distinct from the wellness visit components. **Advance Care Planning:** 99497 denied when the note does not document voluntary patient participation and specific topics discussed.

Common SLP denials: shared PT/SLP therapy cap exhaustion, cognitive therapy documentation failing to link cognition to communication function, swallowing study authorization gaps, maintenance therapy determination, repeat evaluation frequency, and group therapy coding errors.

Common SLP denials: **Shared Therapy Cap Exhaustion:** SLP claims denied because the combined PT/SLP $2,410 cap is already exhausted by PT services — requires coordination between PT and SLP providers. **Cognitive Therapy Medical Necessity:** 92507 denied for cognitive-communication treatment when documentation does not clearly link cognitive deficits (memory, attention, executive function) to specific communication functional limitations. **Swallowing Study Authorization:** MBSS/FEES denied without documented clinical swallowing evaluation (92610) showing signs of aspiration or dysphagia severity warranting instrumental assessment. **Maintenance Therapy:** SLP services denied when documentation suggests the patient has plateaued and treatment is maintaining rather than improving function — each session must show progress toward functional communication or swallowing goals. **Evaluation Frequency:** Repeat SLP evaluations denied within 12 months without documented change in condition or new diagnosis. **Group Therapy Rate:** 97150 (group therapy) denied when group size exceeds payer limits or when individual service codes are billed for services delivered in a group setting.

Common sports medicine denials: athletic trainer credential denial, PRP/regenerative therapy as experimental, performance enhancement vs medical necessity, workers comp documentation gaps, arthroscopy conservative treatment requirements, and concussion testing frequency limits.

Top sports medicine denials: **Athletic Trainer Services:** Claims denied when AT services are billed under the AT's own credentials — many payers require incident-to billing under a supervising physician. **PRP/Regenerative Therapy:** PRP (0232T) and stem cell injections denied as experimental/non-covered by virtually all payers — must be billed as patient-pay and not submitted to insurance. **Performance Enhancement:** Services denied as not medically necessary when documentation focuses on athletic performance improvement rather than treating a diagnosed medical condition. **Workers Comp Documentation:** Claims denied for insufficient injury documentation — must include date of injury, mechanism, employer information, and workers comp claim number. **Arthroscopy Medical Necessity:** Knee/shoulder arthroscopy denied without documented failed conservative treatment (PT, injections, activity modification for 6+ weeks) and positive exam/imaging findings. **Concussion Management Frequency:** Repeat neurocognitive testing denied without documented clinical indication for repeat assessment.

Common ED denials: E/M level downcoding without MDM documentation, critical care time documentation failures, observation/inpatient classification disputes, diagnostic test medical necessity, modifier 25 with procedures, and psychiatric observation coverage.

Top ED denials: **E/M Level Downcoding:** Payer reduces 99285 to 99283 or 99284 when documentation does not support high-complexity medical decision-making — must document differential diagnosis, data reviewed, risk assessment, and management complexity. **Critical Care Time:** 99291 denied without documented total critical care time (minimum 30 minutes) excluding separately billable procedures — must subtract time for intubation, CPR, and other bundled procedures. **Observation vs Inpatient:** Observation hours denied or reclassified when admission criteria are not met or when observation exceeds the two-midnight rule. **Medical Necessity for Testing:** CT scans, troponins, and other diagnostic tests denied without documented clinical indication in the ED note. **Modifier 25 with Procedures:** E/M denied when billed with procedures (laceration repair, fracture care) without modifier 25 and separately documented evaluation beyond the procedure. **Psychiatric Hold:** Prolonged observation for psychiatric patients denied when documentation does not meet medical necessity criteria.

FQHC denials: non-qualifying provider encounters, same-day billing without different provider types, PPS rate disputes, sliding fee documentation gaps, out-of-scope services, and after-hours documentation failures.

Common FQHC denials: **Non-Qualifying Visit:** Encounter denied because the service was not provided by a qualifying provider (e.g., medical assistant, health educator, or social worker without qualifying clinical credentials). **Same-Day Billing:** Two visits on the same day denied when they do not meet the exception criteria (must be different provider types for same-day billing — e.g., medical + mental health). **PPS Rate Disputes:** Medicare Administrative Contractor disputes the FQHC PPS rate when the cost report does not support the rate calculation. **Sliding Fee Scale Documentation:** Claims denied when patient financial documentation for sliding fee discount is incomplete. **Scope of Services:** Services denied when they fall outside the FQHC's HRSA-approved scope of services. **After-Hours/Holiday:** Encounter rate adjustment denied when after-hours or holiday services are not documented with appropriate time stamps and qualifying circumstances.

Common OMS denials: medical/dental coverage classification disputes, orthognathic surgery functional impairment documentation, dual anesthesia billing, TMJ treatment exclusions, and dental implant coverage limitations (medical covers only trauma/cancer/congenital reconstruction).

Common OMS denials: **Medical vs Dental Coverage Determination:** Procedure denied by medical insurance because the payer classifies it as a dental service (e.g., surgical extraction of impacted wisdom teeth), or dental insurance denies it as a medical procedure (e.g., jaw fracture repair). **Orthognathic Surgery Medical Necessity:** Le Fort and mandibular osteotomy denied without documented functional impairment (malocclusion affecting mastication, airway obstruction, TMJ dysfunction), cephalometric analysis, and orthodontic records. **Anesthesia Dual Billing:** Anesthesia denied when both the surgeon's anesthesia service and a separate anesthesia provider bill for the same case. **TMJ Coverage Limitations:** TMJ arthroscopy or open procedures denied by payers that specifically exclude TMJ treatment or require extensive conservative treatment documentation first. **Implant Coverage:** Dental implants denied by medical insurance unless placed for reconstruction after trauma, cancer, or congenital defect — purely restorative implants are typically dental-only or patient-pay.

Common RT denials: incident-to supervision documentation gaps, nebulizer frequency without clinical justification, ventilator management bundled into critical care, inpatient DRG bundling of CPAP/BiPAP, PFT interpretation credential issues, and home equipment DME channel errors.

Common RT denials: **Incident-To Requirements:** RT services denied when direct physician supervision is not documented at the time of service — the supervising physician must be in the office suite, available immediately. **Nebulizer Treatment Frequency:** 94640 denied when performed more frequently than medically justified — documentation must support each treatment with clinical assessment (respiratory rate, SpO2, breath sounds). **Ventilator Management Overlap:** 94002-94004 denied when billed on the same day as critical care (99291-99292) — ventilator management is included in critical care time. **CPAP/BiPAP Initiation:** 94660/94662 denied as facility-bundled when performed in the hospital inpatient setting (DRG payment covers RT services). **PFT Interpretation:** Professional component (modifier 26) for pulmonary function testing denied when the interpreting provider is not a physician or qualified non-physician practitioner. **Home Equipment Crossing:** Home ventilator and oxygen claims denied when submitted as professional medical claims instead of through the DME billing channel.

Genetic testing denials: LCD coverage criteria mismatches, missing CGP prior authorization, unlisted code documentation failures, duplicate testing without clinical rationale, companion diagnostic mismatch, and missing ABN for high-cost non-covered tests.

Common genetic testing denials: **LCD Coverage Criteria:** Genetic tests denied when the ordering diagnosis does not meet the Local Coverage Determination criteria — LCD coverage varies by Medicare Administrative Contractor and changes frequently. **Prior Authorization Missing:** CGP tests (Foundation Medicine, Tempus, Guardant) denied without prior authorization and documented clinical utility — must show how results will impact treatment decisions. **Unlisted Code Documentation:** Tests billed with 81479 (unlisted molecular pathology) denied without comparison to a reference CPT code, methodology description, and clinical utility justification. **Duplicate Testing:** Denied when the same genetic test is repeated within the payer's allowed timeframe without documented clinical rationale (new diagnosis, treatment failure, tumor progression). **Companion Diagnostic Mismatch:** Genetic test denied when there is no FDA-approved targeted therapy linked to the specific biomarker being tested — payers increasingly require companion diagnostic rationale. **Patient Financial Liability:** Unbilled ABN results in the lab absorbing $2,000-$10,000+ for non-covered tests.

Common GI denials: colonoscopy bundling (diagnostic with surgical), screening age/frequency violations, missing modifier PT, polypectomy overcoding for same-technique removals, EGD medical necessity without documented symptoms, and pathology-endoscopy mismatches.

Top GI denials: **Colonoscopy Bundling (CO-97):** Billing diagnostic colonoscopy (45378) with a surgical colonoscopy code (45380-45390) — the diagnostic scope is included in any surgical endoscopy code. **Screening Age/Frequency:** Screening colonoscopy denied when patient does not meet age criteria (45+ for average risk as of 2021 guidelines) or interval criteria (every 10 years average risk, 5 years if polyps found). **Modifier PT Missing:** Screening-to-diagnostic conversion without modifier PT causes the patient's preventive benefit to be lost, generating unexpected patient bills and complaints. **Multiple Polypectomy Overcoding:** Billing multiple units of the same polypectomy code when multiple polyps are removed with the same technique — the code includes all polyps removed by that method. **EGD Medical Necessity:** Upper endoscopy denied without documented symptoms (dysphagia, GERD refractory to medication, anemia, weight loss) or alarm features. **Path-Endoscopy Mismatch:** Pathology specimens billed without corresponding biopsy code on the endoscopy claim.

Common endocrinology denials: CGM interpretation without 72-hour minimum data, DEXA frequency violations (every 2 years), GLP-1 step therapy failures, thyroid ultrasound without documented indication, CCM time documentation gaps, and growth hormone testing requirements.

Common endocrinology denials: **CGM Interpretation (95251):** Denied without minimum 72 hours of continuous data, or when the interpretation report does not document specific findings and treatment modifications. **DEXA Frequency:** Bone density denied when performed more often than every 2 years (Medicare) without documented clinical indication for earlier repeat (new fracture, medication change). **GLP-1 Agonist Prior Auth:** Medications like Ozempic, Trulicity, and Mounjaro denied without documented metformin failure or intolerance (step therapy). **Thyroid Ultrasound Medical Necessity:** Denied without documented thyroid nodule, abnormal exam finding, or abnormal thyroid function tests. **CCM Time Documentation:** 99490/99491 denied when the required minimum monthly time (20 or 30 minutes) is not documented with specific activities performed. **Growth Hormone Therapy:** Denied without documented GH stimulation test results and bone age assessment for pediatric patients.

Common neurosurgery denials: conservative treatment documentation gaps for spine surgery, add-on code sequencing errors, instrumentation without fusion code, co-surgeon documentation failures (modifier 62), global period violations, and prior authorization failures.

Top neurosurgery denials: **Medical Necessity for Spine Surgery:** Denied without documented conservative treatment failure (physical therapy, injections, medications for 6+ weeks), objective neurological findings, and correlating imaging (MRI showing nerve compression). **Multi-Level Coding Errors:** Add-on codes billed without the primary code, or primary code billed at wrong level — code sequencing must match operative report. **Instrumentation Without Fusion:** Hardware codes denied when billed without corresponding fusion code — instrumentation is adjunct to fusion, not standalone. **Co-Surgeon Documentation:** Modifier 62 denied when both surgeons do not submit separate operative notes documenting their distinct portions of the procedure. **Global Period Violations:** Post-op E/M visits billed without modifier 24 and unrelated diagnosis during the 90-day global. **Prior Authorization:** Complex spine cases (multi-level fusions, revisions, artificial disc replacement) frequently require pre-auth with specific clinical criteria.

Common plastic surgery denials: cosmetic classification of reconstructive procedures, blepharoplasty without visual field testing, WHCRA coverage violations, unlisted code documentation failures, prior authorization gaps, and staged procedure timing issues.

Top plastic surgery denials: **Cosmetic Determination:** Payer classifies procedure as cosmetic despite reconstructive intent — requires appeal with detailed medical necessity letter, photographs, and functional documentation. **Blepharoplasty Visual Field Testing:** Upper lid blepharoplasty denied without visual field testing showing >30% superior visual field loss and documented functional impact on daily activities. **Breast Reconstruction WHCRA Violations:** Payer denying contralateral breast symmetry procedures or prosthesis — federal law requires coverage; appeal with WHCRA reference. **Unlisted Procedure Code Documentation:** Claims with unlisted codes (15999, 19499) denied for insufficient documentation — must include operative report, comparable CPT code reference, and time/complexity comparison. **Prior Authorization:** Complex reconstructive procedures denied for missing pre-authorization with photographs and medical records. **Staged Procedure Timing:** Second-stage procedures denied when performed too soon or too late relative to payer's expected staging timeline.

Common podiatry denials: routine foot care without Q modifiers and systemic condition documentation, bunionectomy conservative treatment gaps, orthotic coverage documentation failures, wound care frequency limits, modifier 25 insufficiency, and bilateral staging requirements.

Top podiatry denials: **Routine Foot Care (CO-96):** Nail debridement and callus removal denied as routine care — missing Q7/Q8/Q9 modifier or missing documentation of qualifying systemic condition and class finding. **Bunionectomy Medical Necessity:** Denied without documented conservative treatment failure (shoe modifications, padding, orthotics, NSAIDs) and functional impairment documentation (difficulty walking, inability to wear shoes). **Orthotic Coverage (L3000):** Custom orthotics denied without biomechanical exam documentation, casting/scanning records, and qualifying diagnosis (plantar fasciitis, metatarsalgia, diabetic foot). **Wound Care Frequency:** Diabetic foot wound debridement denied when performed more frequently than payer allows without documented wound progression. **E/M with Procedure:** Modifier 25 denied when nail care or callus removal is the only service and the E/M note does not document a separately identifiable evaluation. **Bilateral Procedures:** Foot surgery denied bilaterally on same day when payer requires staged procedures.

Common urgent care denials: E/M overcoding, modifier 25 documentation insufficiency, same-day ED duplicate service, after-hours code non-recognition, x-ray interpretation credential issues, and workers comp routing errors.

Top urgent care denials: **E/M Level (CO-11):** Overcoding E/M — billing 99215 for a straightforward UTI or ankle sprain without documenting the complexity that supports level 5 medical decision-making. **Modifier 25 (CO-97):** E/M denied when billed with a procedure but the documentation does not show a separately identifiable evaluation — the E/M note only documents the procedure indication. **Duplicate Claims:** Patient visits urgent care and then the ED the same day for the same complaint — payer denies one as duplicate service. **After-Hours Codes:** 99051 denied by payers that do not recognize the code or consider urgent care to be always open (not qualifying for after-hours billing). **X-Ray Over-Reading:** Professional component (modifier 26) for x-ray interpretation denied when the urgent care provider does not have documented radiology interpretation credentials. **Workers Comp Billing Errors:** Claims submitted to commercial insurance instead of workers comp carrier, or WC claims missing required employer/injury information.

Common chiropractic denials: maintenance care determination, missing AT modifier on Medicare claims, subluxation documentation failures (PART criteria), visit limit exceeded, ancillary services denied alongside CMT, and modifier 25 E/M insufficiency.

Top chiropractic denials: **Maintenance Care (CO-50):** Manipulation denied as maintenance/not medically necessary when documentation fails to show objective functional improvement — every visit must document measurable progress toward treatment goals. **Missing AT Modifier:** Medicare denies CMT without AT modifier certifying active corrective treatment. **Subluxation Documentation:** Denied without x-ray findings or physical exam documenting 2+ PART criteria (Pain, Asymmetry, Range of motion, Tissue changes). **Visit Limit Exceeded:** Claims denied after exceeding annual visit cap (varies by payer: 12-30/year) — requires tracking and patient notification. **Ancillary Services Bundled:** Electrical stimulation, ultrasound, and manual therapy denied as bundled with or not covered alongside manipulation. **E/M Modifier 25:** E/M denied when billed with CMT without documenting a separately identifiable evaluation beyond the manipulation encounter.

Common anesthesia denials: start/stop time documentation gaps, medical direction (7 conditions) documentation failures, concurrent case violations (>4), base unit code errors, physical status modifier documentation, and CRNA/anesthesiologist duplicate billing.

Top anesthesia denials: **Time Documentation:** Denied when anesthesia record does not clearly document start and stop times, or when time units are inconsistent with the surgical record. **Medical Direction Requirements:** QK/QY modifier denied when documentation does not prove the anesthesiologist performed all 7 required medical direction conditions (pre-anesthetic exam, prescribe plan, participate in key portions, immediately available, monitor the course, post-anesthesia care, present for emergence). **Concurrent Case Violations:** Billing full time for cases where the anesthesiologist was directing more than 4 concurrent cases. **Base Unit Errors:** Incorrect base unit assignment — using the wrong anesthesia CPT code for the surgical procedure performed. **Physical Status Modifier:** P3-P6 modifier units denied without supporting documentation of the patient's physical status in the pre-anesthesia evaluation. **CRNA vs Anesthesiologist Overlap:** Duplicate billing when both the CRNA and the anesthesiologist bill for the same case without proper direction/supervision modifiers.

Top lab denials: CO-50 medical necessity (diagnosis-test mismatch), panel bundling errors, missing ABNs for non-covered tests, molecular test authorization failures, duplicate/frequency limit violations, and modifier errors (59, QW).

Top laboratory denials: **CO-50 Medical Necessity:** The #1 lab denial — diagnosis code on the requisition does not match payer NCD/LCD coverage criteria for the ordered test. Prevention: automated diagnosis-to-test validation before performing the test. **Panel Bundling (CO-97):** Individual components billed when a panel code applies, or panel billed when not all components were performed. **ABN Missing:** Non-covered test performed without obtaining ABN — the lab absorbs the cost (cannot bill patient). **Molecular Test Authorization:** Genetic and molecular tests denied at 2-3x the rate of routine tests due to missing prior authorization, narrow LCD coverage, or insufficient documentation. **Duplicate Testing:** Same test billed twice on the same date of service, or repeat testing within payer frequency limits. **Modifier Errors:** Missing modifier 59 for distinct tests or QW modifier for CLIA-waived point-of-care tests.

Common pediatric denials: well-child/sick visit split billing errors, vaccine counseling documentation, developmental screening frequency limits, age-group code mismatches, newborn care overlap, and vaccine component count errors.

Top pediatric denials: **Well-Child + Sick Visit Split:** Preventive visit (99391-99395) denied when billed with same-day problem-oriented E/M without modifier 25 and clear documentation separating the two services. **Vaccine Administration:** 90460 denied without documented counseling, or denied when billed for VFC vaccines that should only have administration charges. **Developmental Screening Frequency:** 96110 denied when billed outside of recommended screening ages (9, 18, 30 months per AAP guidelines) without documented clinical concern. **Age-Based Code Mismatch:** Using wrong age-group preventive code (e.g., billing 99393 for a 12-year-old when 99394 is correct for ages 12-17). **Newborn Care Overlap:** 99460 denied when billed on the same day as a hospital admit code or when the attending and consulting physician both bill initial newborn care. **Multiple Component Errors:** Billing more 90461 add-on units than the vaccine actually contains — must match the number of antigens in each vaccine.

Common pathology denials: specimen level miscoding, IHC medical necessity without clinical indication, molecular test LCD coverage failures, duplicate specimen billing, same-group consultation billing, and cytopathology method/code mismatches.

Top pathology denials: **Specimen Level Errors:** Billing at the wrong pathology level — upcoding (88307 for a simple skin biopsy that should be 88305) or downcoding (88304 for a needle biopsy that should be 88305). **IHC Medical Necessity:** Immunohistochemistry (88341-88344) denied without documented clinical indication — must demonstrate how IHC results will change diagnosis or treatment. **Molecular Test Coverage:** Molecular pathology codes denied under narrow LCD coverage criteria — pre-verify coverage before performing expensive molecular testing. **Duplicate Specimens:** Billing multiple pathology codes for fragments from the same anatomic site that should be accessioned as a single specimen. **Consultation Billing:** 88321-88325 denied when the referring pathologist and the consulting pathologist are in the same group practice. **Cytopathology Method:** Billing thin-prep Pap (88142) when conventional Pap (88164) was performed, or billing physician interpretation (88141) when automated screening was used.

DME denials: incomplete CMN, missing prior auth for power wheelchairs/CPAP, CPAP compliance failure (4 hr/night, 70% of nights), competitive bidding non-contracted supplier, same/similar equipment rule, and repair vs replace determination.

Top DME denials: **Certificate of Medical Necessity (CMN):** Denied when CMN is incomplete, unsigned by the physician, or does not include qualifying clinical criteria for the specific equipment. **Prior Authorization:** Power wheelchairs, CPAP devices, and certain oxygen equipment require prior auth with supporting documentation (face-to-face evaluation, clinical assessment, mobility limitation documentation). **CPAP Compliance:** CPAP supplies denied after initial 90-day period when the patient does not meet compliance criteria (4+ hours/night on 70% of nights for 30 consecutive days). **Competitive Bidding Pricing:** Claims denied when submitted by a non-contracted supplier in a competitive bidding area. **Same/Similar Equipment:** New equipment denied because the beneficiary already has the same or similar equipment — 5-year reasonable useful life rule applies. **Repair vs Replace:** Replacement denied when the equipment can be repaired at lower cost — must document that repair is not cost-effective.

Pharmacy rejections: PA required (75), refill too soon (79), plan limits exceeded (76), drug not covered (70), DAW brand/generic penalties, and DIR fee clawbacks averaging 10-15% of reimbursement.

Common pharmacy rejections: **Prior Authorization Required (Reject 75):** Non-formulary or step-therapy drugs require PA — submit through payer portal with diagnosis, failed alternatives, and clinical rationale. **Refill Too Soon (Reject 79):** Patient attempting to refill before 75-80% of previous supply consumed — calculate based on last fill date and days supply. **Plan Limitations Exceeded (Reject 76):** Quantity limit, age restriction, or maximum supply exceeded — may require quantity limit exception with clinical documentation. **Drug Not Covered (Reject 70):** Drug excluded from formulary — options include therapeutic alternative, formulary exception request, or manufacturer patient assistance program. **DAW Penalty:** Brand dispensed when generic available without physician DAW code — patient pays full brand cost or pharmacy absorbs difference. **DIR Fee Clawbacks:** Post-adjudication retroactive fees reducing effective reimbursement below acquisition cost — the most significant pharmacy financial challenge, averaging 10-15% of total reimbursement.

Common primary care denials: preventive + problem visit split billing errors, vaccination administration without product code, CCM consent/time documentation, MIPS payment penalties, telehealth modifier/POS errors, and screening frequency violations.

Top primary care denials: **Preventive + Problem Visit Split:** Annual physical (99395) denied when billed with same-day E/M (99214) without modifier 25 and documentation separating the preventive components from the new/existing problem addressed. **Vaccination Administration:** 90471 denied when billed without a separate vaccine product code, or when vaccine is given during a preventive visit that already includes immunization counseling. **CCM Enrollment:** 99490 denied when patient consent is not documented or when the required minimum 20 minutes of clinical staff time per month is not recorded with specific activities. **MIPS Penalty:** Not a claim denial but a payment reduction — practices not meeting MIPS quality reporting thresholds receive negative payment adjustments up to -9%. **Telehealth E/M:** Virtual visits denied without modifier 95, proper POS code (02/10), or documented HIPAA-compliant platform use. **Screening Test Frequency:** Medicare-covered screenings (AWV, depression screening, diabetes screening) denied when performed outside the allowed frequency intervals.

Common OB/GYN denials: global package unbundling errors, premature postpartum visit billing, modifier 22 documentation insufficiency, ultrasound frequency limits without clinical indication, and well-woman/problem visit split billing documentation gaps.

Top OB/GYN denials: **Global Package Unbundling Errors:** Billing individual antepartum visits when the global code applies, or failing to unbundle when a patient transfers care before delivery. **Postpartum Visit Timing:** Billing the postpartum visit before the global period ends (typically 6 weeks post-delivery) — early postpartum visits for complications require documentation of a condition not included in the global package. **Hysterectomy Modifier 22:** Denied without operative note documentation of increased time, complexity, or unusual circumstances — must document specific reasons (adhesion severity, uterine size, anatomic variation). **Ultrasound Medical Necessity:** OB ultrasound denied beyond the standard 1-2 covered per pregnancy without documented clinical indication (bleeding, growth concern, placental issue). **Preventive vs Problem Split:** Well-woman exam denied when billed with problem-oriented E/M without modifier 25 and clear documentation separating the two services.

Allergy denials: testing frequency limits (retesting within 2-3 years), per-session test volume caps, immunotherapy preparation quantity errors, medical necessity for asymptomatic testing, biologic step therapy violations, modifier 25 insufficiency, and skin/blood test duplication.

Common allergy denials: **Testing Frequency:** Repeat allergy testing denied within 2-3 years of initial testing unless documented clinical change justifies retesting. **Test Volume Limits:** Some payers cap percutaneous tests at 50-70 per session — tests beyond the cap are denied. **Immunotherapy Preparation Quantity:** 95165 denied when billed for more doses than the treatment schedule supports. **Medical Necessity for Testing:** Testing denied without documented allergic symptoms — screening asymptomatic patients for allergies is not covered. **Biologic Step Therapy:** Xolair denied without documented failure of standard allergy management (antihistamines, nasal steroids, immunotherapy). **E/M with Injection:** Modifier 25 denied when injection visit documentation shows only the injection without a separately identifiable E/M service. **Skin vs In-Vitro Duplication:** Billing both 95004 and 86003 for the same allergen on the same date.

Common pain management denials: conservative treatment not documented, injection frequency limits exceeded (3 epidurals/year, 2 diagnostic blocks + 1 RFA), missing fluoroscopy documentation, RFA step therapy violation, modifier 25 insufficiency, and UDS frequency limits.

Top pain management denials: **Medical Necessity:** Injections denied without documented conservative treatment failure (physical therapy, medications, activity modification for 4-6 weeks). **Frequency Limits:** Most payers limit epidural injections to 3 per region per year, and facet injections to 2 diagnostic + 1 RFA per year — exceeding these triggers automatic denial. **Missing Imaging Guidance Documentation:** Procedure denied when fluoroscopy or CT guidance images are not saved or documented in the record. **Step Therapy for RFA:** Radiofrequency ablation denied without two prior diagnostic medial branch blocks showing 80%+ pain relief. **E/M with Procedure:** Modifier 25 denied when the E/M note does not document a separately identifiable evaluation beyond the procedure decision. **Drug Testing Frequency:** UDS denied when performed more frequently than payer allows (typically monthly for stable patients on chronic opioids).

Common ophthalmology denials: diagnostic test medical necessity, Medicare refraction non-coverage, cataract global period violations, bilateral testing without per-eye justification, frequency limit violations for OCT/visual fields, and modifier 25 insufficiency.

Top ophthalmology denials: **Diagnostic Test Medical Necessity (CO-50):** OCT, visual fields, and fundus photography denied when ICD-10 code does not support the specific test — each test needs a qualifying diagnosis. **Refraction Denial:** Medicare does not cover refraction (92015) — requires ABN and patient financial responsibility documentation. **Cataract Surgery Global Period:** Post-op visits billed separately during the 90-day global without modifier 24 and unrelated diagnosis. **Bilateral Testing:** Bilateral OCT or visual fields denied when performed on both eyes without clinical justification for each eye. **Frequency Limits:** Visual field testing (92083) and OCT limited to specific intervals per eye by many payers — billing more frequently without documented progression results in denial. **E/M with Injection:** Modifier 25 denied when the E/M documentation does not show a separately identifiable service beyond the injection decision.

Top pulmonology denials: PFT bundling (94010 inside 94060), bronchoscopy diagnostic add-on errors, critical care time documentation gaps, sleep study authorization (HST before PSG), oxygen qualification criteria failures, and pulmonary rehab medical necessity.

Common pulmonology denials: **PFT Bundling:** Billing spirometry (94010) separately when 94060 (pre/post bronchodilator) was performed — 94060 includes 94010. **Bronchoscopy Diagnostic Add-On:** Billing diagnostic bronchoscopy (31622) with surgical bronchoscopy codes — the diagnostic component is always included. **Critical Care Time:** Billing 99291 without documenting total critical care time (minimum 30 minutes) or including time spent on separately billable procedures. **Sleep Study Authorization:** Polysomnography denied without home sleep test first (most payers require HST before in-lab PSG for uncomplicated OSA). **Oxygen Qualification:** Home oxygen denied when ABG or pulse oximetry documentation does not meet qualifying criteria (PaO2 ≤55 or SpO2 ≤88% on room air, or PaO2 56-59/SpO2 89% with specific comorbidities). **Pulmonary Rehab Medical Necessity:** Denied without documented COPD severity, functional limitation, and physician prescription.

Common ENT denials: endoscopy bundling errors, septoplasty medical necessity without functional obstruction documentation, multiple procedure sequencing errors, missing sinus surgery prior auth with CT documentation, and global period violations.

Top ENT billing denials: **Bundling (CO-97):** Diagnostic nasal endoscopy (31231) billed separately with surgical endoscopy, turbinate reduction bundled into septoplasty without modifier 59/XS, or bilateral sinus procedures without modifier 50. **Medical Necessity (CO-50):** Septoplasty denied when documentation focuses on cosmetic concern rather than functional obstruction, or sinus surgery denied without documented failed medical management (antibiotics, steroids, nasal sprays). **Multiple Procedure Reduction:** Second and subsequent sinus procedures reduced by 50% — correct sequencing (highest RVU first) is essential. **Prior Authorization:** FESS and septoplasty frequently require prior auth with CT scan documentation showing chronic sinusitis. **Global Period:** Post-op visits billed separately during 90-day global period without modifier 24 and unrelated diagnosis.

Infusion denials: J-code unit miscalculation (e.g., 400mg infliximab = 40 units of J1745), missing weight documentation, incomplete infusion time records, outdated disease activity scores, site-of-service steering, and biosimilar mandate violations.

Rheumatology infusion denials: **Drug Unit Errors:** Infliximab (J1745) is billed per 10mg — a 400mg dose = 40 units, not 4 or 400. Unit miscalculation is the most common infusion billing error. **Weight-Based Dosing Documentation:** Many biologics (infliximab, rituximab, tocilizumab) are weight-based — the patient's current weight must be documented on the date of service. **Infusion Time Documentation:** Start and stop times must be documented for each drug and each infusion interval. 96413 covers the first hour; 96415 requires >30 minutes beyond the prior hour. **Medical Necessity:** Continued therapy denied when disease activity scores are not updated or show inadequate response. **Site-of-Service Steering:** Some payers deny office-based infusions and require home infusion or hospital outpatient — know your payer contracts. **Biosimilar Mandates:** Payers increasingly require biosimilar use before brand biologic — submit biosimilar J-codes or face non-formulary denials.

Common urology denials: bilateral modifier 50 errors, medical necessity for PSA/imaging, bundling of cystoscopy with other endoscopic procedures, global period E/M violations, and site-of-service code mismatches.

Top urology claim denials: **Modifier Errors (CO-4):** Missing bilateral modifier 50 for bilateral procedures, or incorrect use of modifier 25 when billing E/M with same-day cystoscopy — prevented by automated modifier validation. **Medical Necessity (CO-50):** PSA screening without qualifying diagnosis, urodynamics without documented voiding symptoms, or imaging without clinical indication — prevented by diagnosis-to-procedure mapping. **Bundling (CO-97):** Cystoscopy bundled with other endoscopic procedures performed in the same session, or post-void residual billed separately when bundled into E/M — use modifier 59/XS only when procedures are truly distinct. **Global Period Violations:** Billing E/M visits during 90-day surgical global without modifier 24 and an unrelated diagnosis. **Site-of-Service:** Billing facility fees for office-based procedures or using wrong place-of-service code.

Common nephrology denials: MCP visit count documentation gaps, billing labs bundled into ESRD PPS, vascular access procedure documentation failures, overlapping MCP and E/M for same diagnosis, and billing facility-bundled services under physician claims.

Top nephrology denials: **MCP Visit Count Discrepancies:** Billing 90960 (4+ visits) when documentation only supports 3 visits — every visit must have a separate encounter note with date, time, and medical decision-making. **ESRD Lab Bundling:** Billing labs separately that are included in the ESRD PPS bundle (CBC, CMP, phosphorus, PTH, iron studies, hepatitis B) — only non-bundled tests can be billed separately. **Vascular Access Procedure Denials:** Missing pre-operative imaging documentation, or billing both open and percutaneous approaches without modifier 59 for distinct procedures. **Overlapping MCP and E/M:** Billing E/M codes for the same diagnosis covered under the MCP during the same month — MCP is an all-inclusive code. **Dialysis Adequacy Testing:** Billing KTV (90999) studies when they are included in the facility PPS payment rather than the physician service.

Common orthopedic denials: prior auth for major procedures, global period E/M violations, bilateral modifier errors, fracture care overlap with ED management, implant documentation gaps, and workers comp treatment authorization requirements.

Top orthopedic denials: **Prior Authorization:** Joint replacement, spine surgery, and arthroscopy denied without pre-authorization and documented conservative treatment failure (PT, injections, medications for 6+ weeks). **Global Period Violations:** Post-operative visits billed separately during the 90-day global without modifier 24 and an unrelated diagnosis. **Bilateral Modifier Errors:** Bilateral procedures billed without modifier 50 or billed with incorrect modifier combinations. **Fracture Care Overlap:** Billing both emergency department fracture management and the orthopedic surgeon's definitive fracture care — the surgeon's global fracture care code includes the initial treatment. **Implant Documentation:** Hardware/prosthetic component charges denied without operative note documentation of specific implant type, size, and manufacturer. **Workers Comp Authorization:** Treatment beyond initial visit denied without utilization review approval in states requiring treatment guidelines compliance.

Oncology denial impacts: drug unit calculation errors on high-cost drugs, medical necessity denials for off-label use, expired prior auth on $5K-$50K infusions, and buy-and-bill cash flow risk when denied claims leave practices absorbing drug costs.

Oncology claim denials are financially devastating due to high drug costs: **Drug Unit Calculation Errors:** Incorrect J-code units are the most common error — billing 200 units instead of 20 (or vice versa) for a $15,000 drug. **Medical Necessity (CO-50):** Off-label drug use without NCCN Compendium support, or treatment continuation without documented response assessment. **Prior Authorization Failure:** Expired or missing auth for chemotherapy regimens — a single denied infusion can mean $5,000-$50,000 in unrecoverable revenue. **Sequestration/Payment Adjustments:** Medicare sequestration reduces payments by 2%, and ASP-based reimbursement may fall below acquisition cost for some drugs. **Timely Filing:** Complex oncology claims with multiple drugs and services often miss filing deadlines during appeals — track every claim from day one. **Buy-and-Bill Cash Flow Risk:** When a $20,000 drug claim is denied, the practice has already purchased and administered the drug — the financial exposure is immediate and significant.

Top PT denials: medical necessity (CO-50), therapy cap exceeded without KX modifier, expired authorization, unsigned plan of care, missing PTA modifier (CQ), and time-overlap bundling errors. Prevention requires automated tracking systems and documentation protocols.

The most common PT denial reasons are: **Medical Necessity (CO-50):** Treatment no longer shows objective functional improvement, or documentation does not support continued skilled care — prevented by measurable progress documentation at every visit. **Therapy Cap Exceeded (CO-119):** KX modifier missing on claims above the $2,410 cap — prevented by automated cap tracking and modifier application. **Authorization Expired (CO-15):** Visits exceeded authorized number or auth period expired — prevented by authorization tracking with automated alerts at 80% utilization. **Plan of Care Not Certified (CO-4):** Physician signature missing or late on the plan of care — prevented by a 72-hour signature tracking workflow. **PTA Modifier Missing:** CQ modifier not appended to services performed by a PTA — prevented by automated modifier logic based on rendering provider credentials. **Bundling Errors:** Billing multiple codes for overlapping time periods — prevented by the 8-minute rule validation before submission.